+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

Geography & Life Sciences: Chapter 54352

Chapter 54352 provides bibliographic information on scholary research in geography and in the life sciences.

Metatarsal osteosarcoma in Rothmund-Thomson syndrome: a case report. Journal of Bone and Joint Surgery. American Volume 92(3): 726-730

Metatarsal pain of systemic origin. Journal of the National Association of Chiropodists 37(6): 28-28

Metatarsal protrusion angle: values of normality. Journal of the American Podiatric Medical Association 99(1): 49-53

Metatarsal reconstruction with use of free vascularized osteomyocutaneous fibular grafts following resection of malignant tumors of the midfoot. A series of six cases. Journal of Bone and Joint Surgery. American Volume 89(7): 1553-1564

Metatarsal stress fracture diagnosed with high-resolution sonography. Journal of Ultrasound in Medicine 29(3): 473-476

Metatarsal stress fractures in patients with multiple myeloma treated with long-term bisphosphonates: a report of six cases. Journal of Bone and Joint Surgery. American Volume 93(18): E106-E106

Metatarsal stress fractures secondary to soft-tissue osteochondroma in the foot: case report and literature review. Foot and Ankle Surgery 17(4): E51-E54

Metatarsalgia and neuropathies of the foot. Differential diagnosis. Revista de Neurologia 52(1): 37-44

Metatarsalgia, lesser toe deformities, and associated disorders of the forefoot. Medical Clinics of North America 98(2): 233-251

Metatarsalgia: an ultrasound perspective. Australasian Radiology 51(6): 493-499

Metatarsalgia: distal metatarsal osteotomies. Foot and Ankle Clinics 16(4): 583-595

Metatarsalgia: proximal metatarsal osteotomies. Foot and Ankle Clinics 16(4): 597-608

Metatarsalgia; painful foot, Morton's syndrome, march fracture; a physiologic entity. Proceedings. American Federation for Clinical Research 2: 105-105

Metatarsals in the estimation of stature in South Africans. Journal of Forensic and Legal Medicine 15(8): 505-509

Metatarso-sesamoid osteoarthritis as a cause of pain after first metatarsophalangeal joint fusion: case report. Foot & Ankle International 32(8): 822-825

Metatarsocuneiform joint resection arthroplasty for atraumatic osteoarthrosis: an alternative to arthrodesis. Journal of Foot and Ankle Surgery 52(1): 122-124

Metatarsophalangeal arthritis following fourth metatarsal lengthening treated with distraction arthroplasty: case report. Foot & Ankle International 35(10): 1075-1081

Metatarsophalangeal arthrodesis of the hallux and arthroplastic resection of the second to fifth metatarsal heads in the rheumatic foot. Acta Ortopedica Mexicana 27(2): 78-86

Metatarsophalangeal joint arthroplasty with implantation of Osteomed Interflex IPG system: our experience. Acta Bio-Medica 85 Suppl 2: 118-120

Metatarsophalangeal joint function during sprinting: a comparison of barefoot and sprint spike shod foot conditions. Journal of Applied Biomechanics 30(2): 206-212

Metatarsophalangeal joint fusion of the great toe. Orthopedics 1(6): 462-467

Metatarsophalangeal joint instability of the lesser toes and plantar plate deficiency. Journal of the American Academy of Orthopaedic Surgeons 22(4): 235-245

Metatarsophalangeal joint pain in psoriatic arthritis: a cross-sectional study. Rheumatology 53(4): 737-740

Metatarsophalangeal joint pathology in crossover second toe deformity: a cadaveric study. Foot & Ankle International 33(2): 133-140

Metatarsus Primus Elevatus. Proceedings of the Royal Society of Medicine 31(11): 1273-1273

Metatarsus Varus among Forefoot Adduction Deformities in Children.. Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca 63(4): 221-225

Metatarsus adductovarus: skewfoot. Journal of the American Medical Association 141(7): 449-453

Metatarsus adductus angle in male and female feet: normal values with two measurement techniques. Journal of the American Podiatric Medical Association 98(5): 364-369

Metatarsus primus varus correction: the osteotomies. Clinics in Podiatric Medicine and Surgery 26(3): 409-25, Table of Contents

Metatarsus quintus valgus. British Medical Journal 1(4606): 664-664

Metatarsus virus. California Medicine 69(5): 346-348

Metataxonomic profiling and prediction of functional behaviour of wheat straw degrading microbial consortia. Biotechnology for Biofuels 7(): 92-92

Metatheory, change and evidence-based medicine. A commentary on Isaac & Franceschi (2008). Journal of Evaluation in Clinical Practice 14(5): 660-662

Metathesis Cascade Strategies (ROM-RCM-CM): A DOS approach to Skeletally Diverse Sultams. Tetrahedron 65(26): 4992-5000

Metathesis access to monocyclic iminocyclitol-based therapeutic agents. Beilstein Journal of Organic Chemistry 7: 699-716

Metathesis assisted synthesis of cyclic peptides. Chemical Communications: 295-297

Metathesis catalysts in confining reaction fields--confinement effects vs. surface effects. Dalton Transactions: 577-584

Metathesis in single crystal: complete and reversible exchange of metal ions constituting the frameworks of metal-organic frameworks. Journal of the American Chemical Society 131(11): 3814-3815

Metathesis in the synthesis of aromatic compounds. Chemical Reviews 109(8): 3743-3782

Metathesis in total synthesis. Chemical Communications 47(23): 6505-6511

Metathesis of alkanes and related reactions. Accounts of Chemical Research 43(2): 323-334

Metathesis of fatty acid ester derivatives in 1,1-dialkyl and 1,2,3-trialkyl imidazolium type ionic liquids. International Journal of Molecular Sciences 12(6): 3989-3997

Metathesis of nitrogen atoms within triple bonds involving carbon, tungsten, and molybdenum. Inorganic Chemistry 47(12): 5377-5385

Metathesis reaction of hydrocarbyl ligands across the triruthenium plane. Angewandte Chemie 49(34): 5898-5901

Metathesis reactions of a manganese borylene complex with polar heteroatom-carbon double bonds: a pathway to previously inaccessible carbene complexes. Journal of the American Chemical Society 135(23): 8726-8734

Metathesis transformations of natural products: cross-metathesis of natural rubber and mandarin oil by Ru-alkylidene catalysts. Molecules 17(5): 6001-6010

Metathesis within self-assembled gels: transcribing nanostructured soft materials into a more robust form. Langmuir 25(15): 8786-8793

Metathesis-like splitting reactions of metallated [36]octaphyrins( experimental and computational investigations. Chemistry 15(23): 5674-5685

Metathesis-mediated synthesis of (R)-10-methyl-2-tridecanone, the southern corn rootworm pheromone. Bioscience, Biotechnology, and Biochemistry 76(2): 407-409

Metatraits of the Big Five differentially predict engagement and restraint of behavior. Journal of Personality 77(4): 1085-1102

Metatranscriptome analysis for insight into whole-ecosystem gene expression during spontaneous wheat and spelt sourdough fermentations. Applied and Environmental Microbiology 77(2): 618-626

Metatranscriptome analysis of fungal strains Penicillium camemberti and Geotrichum candidum reveal cheese matrix breakdown and potential development of sensory properties of ripened Camembert-type cheese. Bmc Genomics 15(): 235-235

Metatranscriptome analysis of the human fecal microbiota reveals subject-specific expression profiles, with genes encoding proteins involved in carbohydrate metabolism being dominantly expressed. Applied and Environmental Microbiology 76(16): 5533-5540

Metatranscriptome of an anaerobic benzene-degrading, nitrate-reducing enrichment culture reveals involvement of carboxylation in benzene ring activation. Applied and Environmental Microbiology 80(14): 4095-4107

Metatranscriptomes from diverse microbial communities: assessment of data reduction techniques for rigorous annotation. Bmc Genomics 15(): 901-901

Metatranscriptomic analyses of plankton communities inhabiting surface and subpycnocline waters of the Chesapeake Bay during oxic-anoxic-oxic transitions. Applied and Environmental Microbiology 80(1): 328-338

Metatranscriptomic analysis of arctic peat soil microbiota. Applied and Environmental Microbiology 80(18): 5761-5772

Metatranscriptomic analysis of ectomycorrhizal roots reveals genes associated with Piloderma-Pinus symbiosis: improved methodologies for assessing gene expression in situ. Environmental Microbiology 16(12): 3730-3742

Metatranscriptomic analysis of small RNAs present in soybean deep sequencing libraries. Genetics and Molecular Biology 35(1 ): 292-303

Metatranscriptomic analysis of sulfur oxidation genes in the endosymbiont of solemya velum. Frontiers in Microbiology 2: 134-134

Metatranscriptomic analysis of the response of river biofilms to pharmaceutical products, using anonymous DNA microarrays. Applied and Environmental Microbiology 76(16): 5432-5439

Metatranscriptomic and functional metagenomic analysis of methylphosphonate utilization by marine bacteria. Frontiers in Microbiology 4: 340-340

Metatranscriptomic approach to analyze the functional human gut microbiota. Plos One 6(3): E17447-E17447

Metatranscriptomic array analysis of 'Candidatus Accumulibacter phosphatis'-enriched enhanced biological phosphorus removal sludge. Environmental Microbiology 12(5): 1205-1217

Metatranscriptomics of the human oral microbiome during health and disease. Mbio 5(2): E01012-14

Metatranscriptomics reveals the diversity of genes expressed by eukaryotes in forest soils. Plos One 7(1): E28967-E28967

Metatropic dysplasia as the cause of atlantoaxial instability, spinal stenosis and myelopathy: case report and literature review. Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca 79(2): 169-174

Metatropic dysplasia in children. Mymensingh Medical Journal 17(1): 93-97

Metatropic dysplasia in four-year-old boy--physiotherapy and orthopaedic care problems--case report. Ortopedia, Traumatologia, Rehabilitacja 14(3): 289-302

Metatypical basal cell carcinoma: a clinical review. Journal of Experimental & Clinical Cancer Research 27(): 65-65

Metatypical basal-cell carcinoma (MTC) or basosquamos carcinoma (BSC): surgical therapy. Annali Italiani di Chirurgia 82(5): 389-394

Metatypical carcinoma of the head: a review of 312 cases. European Review for Medical and Pharmacological Sciences 16(14): 1915-1918

Metatypical carcinoma. A review of 327 cases. Annali Italiani di Chirurgia 82(2): 131-135

Metavanadate as a reagent for the colorimetric determination of acids. Talanta 24(5): 333-334

Metavanadate at the active site of the phosphatase VHZ. Journal of the American Chemical Society 134(35): 14298-14301

Metaversion can reliably predict humeral head version: a computed tomography-based validation study. Journal of Shoulder and Elbow Surgery 19(8): 1145-1149

Metavir 2: new tools for viral metagenome comparison and assembled virome analysis. Bmc Bioinformatics 15(): 76-76

Metavir: a web server dedicated to virome analysis. Bioinformatics 27(21): 3074-3075

Metaweaves: sector-way nonreciprocal metasurfaces. Physical Review Letters 112(15): 153901-153901

Metaxalone estimation in biological matrix using high-throughput LC-MS/MS bioanalytical method. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 902: 132-136

Metaxin deficiency alters mitochondrial membrane permeability and leads to resistance to TNF-induced cell killing. Protein & Cell 1(2): 161-173

Metaxins 1 and 2, two proteins of the mitochondrial protein sorting and assembly machinery, are essential for Bak activation during TNF alpha triggered apoptosis. Cellular Signalling 26(9): 1928-1934

Metaxonchium persicum sp. n. from Iran (Nematoda, Dorylaimida, Belondiridae), with an updated taxonomy of the genus. Zootaxa 3785: 501-517

Metazoa immune receptors diversification during evolution. Medecine Sciences 25(3): 273-280

Metazoal Immunity: (Section of Comparative Medicine). Proceedings of the Royal Society of Medicine 31(11): 1291-1298

Metazoan cell biology of the HOPS tethering complex. Cellular Logistics 1(3): 111-117

Metazoan endoparasites diversity of Pseudoplatystoma corruscans (Siluriformes: Pimelodidae) as an indicator of environmental alterations on a tropical aquatic system. Acta Parasitologica 59(3): 398-404

Metazoan endoparasites of Pygocentrus nattereri (Characiformes: Serrasalminae) in the Negro River, Pantanal, Brazil. Revista Brasileira de Parasitologia Veterinaria 22(3): 331-338

Metazoan endoparasites of Serrasalmus marginatus (Characiformes: Serrasalminae) in the Negro River, Pantanal, Brazil. Revista Brasileira de Parasitologia Veterinaria 20(1): 61-63

Metazoan gill parasites of the Atlantic bluefin tuna Thunnus thynnus (Linnaeus) (Osteichthyes: Scombridae) from the Mediterranean and their possible use as biological tags. Folia Parasitologica 61(2): 148-156

Metazoan parasite communities of catfishes (Teleostei: Siluridae) in Benin (West Africa). Parasitology Research 113(11): 3973-3983

Metazoan parasite community of blue sea catfish, Sciades guatemalensis (Ariidae), from Tres Palos Lagoon, Guerrero, Mexico. Parasitology Research 105(4): 997-1005

Metazoan parasite infection in the swordfish, Xiphias gladius, from the Mediterranean Sea and comparison with Atlantic populations: implications for its stock characterization. Parasite 21: 35-35

Metazoan parasites from herring (Clupea harengus L.) as biological indicators in the Baltic Sea. Acta Parasitologica 59(3): 518-528

Metazoan parasites in the head region of the bullet tuna Auxis rochei (Osteichthyes: Scombridae) from the western Mediterranean Sea. Journal of Helminthology 89(6): 734-739

Metazoan parasites of Mandi-amarelo Pimelodus maculatus and of Jundiá Rhamdia quelen (Osteichthyes: Siluriformes) of Paraíba do Sul River, Volta Redonda, Rio de Janeiro. Revista Brasileira de Parasitologia Veterinaria 19(3): 157-163

Metazoan parasites of Mystus vittatus (Bloch) of River Godavari with description of a new species of Acanthocephala, Raosentis godavarensis sp. nov. Journal of Parasitic Diseases 33(1-2): 77-83

Metazoan parasites of roach Rutilus rutilus (L., 1758), bream Abramis brama (L., 1758) and perch Perca fluviatilis L., 1758 from lakes of river Łyna watershed. Wiadomosci Parazytologiczne 56(1): 81-82

Metazoan parasites of the Indian mackerel, Rastrelliger kanagurta (Scombridae) of Visakhapatnam coast, Bay of Bengal. Journal of Parasitic Diseases 35(1): 66-74

Metazoan parasites of the common carp (Cyprinus carpio L., 1758) from Tahtalı Dam Lake (İzmir). Turkiye Parazitolojii Dergisi 36(3): 174-177

Metazoan parasites on the gills of the skipjack tuna Katsuwonus pelamis (Osteichthyes: Scombridae) from the Alboran Sea (western Mediterranean Sea). Diseases of Aquatic Organisms 97(3): 219-225

Metazoan stress granule assembly is mediated by P-eIF2alpha-dependent and -independent mechanisms. Rna 15(10): 1814-1821

Metazoan symbionts of the yellow clam, Mesodesma donacium (Bivalvia), in southern Chile: geographical variations. Journal of Parasitology 100(6): 797-804

Metazoan transitions. Science 268(5214): 1208-1208

Meta‐analysis of genetic variants associated with human exceptional longevity. Aging 5(9): 653-661

Metchnikoff and a century of probiotics. From intuition to science. La Pediatria Medica E Chirurgica 30(4): 215-219

Metchnikoff and the microbiome. Lancet 380(9856): 1810-1811

Meteo-U-rology: climate impact on urological emergencies. Progres en Urologie 24(9): 535-539

Meteo-climatic conditions influence the contribution of endotoxins to PM10 in an urban polluted environment. Journal of Environmental Monitoring 12(2): 484-490

Meteo-diffusive analysis: a case-study of Turin. Epidemiologia E Prevenzione 33(6 Suppl 1): 27-33

Meteoadaptogenic properties of antihypoxic drugs. Eksperimental'naia i Klinicheskaia Farmakologiia 72(6): 36-41

Meteoadaptogenic properties of peptide drugs in healthy volunteers. Eksperimental'naia i Klinicheskaia Farmakologiia 70(6): 41-47

Meteor Crater, Arizona. Science 104(2689): 38-39

Meteor Trails on the Moon. Science 104(2709): 514-514

Meteor hunt. Scientific American 307(3): 23-23

Meteor-Fall. Science 10(253): 288-288

Meteoric And Terrestrial Rocks. Science 1(5): 127-130

Meteoric Dust. Science 75(1938): 216-216

Meteoric Shower. Science 20(515): 346-346

Meteoric activity, Aug. 10. Science 6(133): 142-142

Meteoric ion layers in the Martian atmosphere. Faraday Discussions 147: 349-68; Discussion 379-403

Meteoric processes: physics of meteoric phenomena. Science 227(4691): 1219-1220

Meteorin promotes the formation of GFAP-positive glia via activation of the Jak-STAT3 pathway. Journal of Cell Science 123(Pt 11): 1959-1968

Meteorin regulates mesendoderm development by enhancing nodal expression. Plos One 9(2): E88811-E88811

Meteorin-like is a hormone that regulates immune-adipose interactions to increase beige fat thermogenesis. Cell 157(6): 1279-1291

Meteorite fail at pueblito de allende, chihuahua, Mexico: preliminary information. Science 163(3870): 928-929

Meteorite impact crater in central alaska. Science 201(4352): 279-280

Meteorite recovery. Science 274(5286): 329a-329a

Meteorites. Science 147(3661): 1061-1062

Meteorites and Craters Campo del Cielo, Argentina. Science 149(3688): 1055-1064

Meteorites and the Moon: Cosmic-ray ages and contaminants provide evidence that meteorites may come from the moon. Science 147(3663): 1262-1265

Meteorites as catalysts for prebiotic chemistry. Chemistry 19(50): 16916-16922

Meteorites: messengers from the early solar system. Chimia 64(10): 736-740

Meteoritic impact and deformation of quartz. Science 160(3827): 526-528

Meteoritics. Siberian meteor spurs dash for data, calls for safeguards. Science 339(6124): 1135-1135

Meteoritics. Sutter's Mill meteorite produces mother lode of research. Science 338(6114): 1521-1521

Meteorologic Conditions in the Causation of Lobar Pneumonia. Transactions of the American Climatological Association for the Year ... American Climatological Association 20: 204-231

Meteorologic conditions and respiratory syncytial virus activity. Pediatric Infectious Disease Journal 31(10): E176-E181

Meteorologic factors may trigger arrhythmogenesis through induction of systemic inflammation and coagulation response: potential antiarrhythmic benefits of mitigating this response in arrhythmia-prone subjects under poor meteorologic conditions?. International Journal of Cardiology 168(5): 4937-4938

Meteorological Bibliographies. Science 18(468): 795-795

Meteorological Charts Of The North Atlantic. Science 3(69): 654-657

Meteorological Conditions of Sunstroke. Transactions of the American Climatological Association for the Year ... American Climatological Association 13: 223-237

Meteorological Conference. Science 7(161): 210-211

Meteorological Doppler radar. Science 182(4109): 258-262

Meteorological Electricity. Science 2(52): 288-288

Meteorological Journal: Kept at Sidmouth. Provincial Medical Journal and Retrospect of the Medical Sciences 6(151): 437-437

Meteorological Notes. Science 18(456): 244-244

Meteorological Observations At The University Of California. Science 37(960): 800-802

Meteorological Observations During An Atlantic Voyage. Science 6(139): 324-325

Meteorological Observations In Germany. Science 41(1045): 65-65

Meteorological Observations On Pike's Peak. Science 15(368): 122-124

Meteorological Observations With Kites At Sea. Science 18(447): 113-114

Meteorological Observations as respects Disease Prevalence. Public Health Papers and Reports 14: 179-182

Meteorological Officers In The Army Air Forces. Science 96(2500): 489-489

Meteorological Phenomena On Mountain Summits. Science 23(591): 672-674

Meteorological Report For New York City For The Week Ending Aug. 20, 1881. Science 2(62): 412-412

Meteorological Results Of The Blue Hill Kite Work. Science 21(533): 433-435

Meteorological Satellites. Science 143(3606): 612-613

Meteorological Training For The Army Air Forces. Science 97(2512): 179-179

Meteorological and agricultural effects on airborne Alternaria and Cladosporium spores and clinical aspects in Valladolid (Spain). Annals of Agricultural and Environmental Medicine 16(1): 53-61

Meteorological and climate change themes at the 2010 International Conference on Emerging Infectious Diseases. Euro Surveillance 15(30): -

Meteorological and intelligence evidence of long-distance transit of chemical weapons fallout from bombing early in the 1991 Persian Gulf War. Neuroepidemiology 40(3): 160-177

Meteorological and pedological influence on the PCBs distribution in mountain soils. Chemosphere 83(2): 186-192

Meteorological aspects of the el nino/southern oscillation. Science 222(4629): 1195-1202

Meteorological conditions affecting the quality of strong gluten- and medium gluten- wheat and climate division in Shandong Province. Ying Yong Sheng Tai Xue Bao 18(10): 2269-2276

Meteorological conditions and acute cardiovascular events; is there any correlation?. Interactive Cardiovascular and Thoracic Surgery 10(3): 406-407

Meteorological conditions and incidence of Legionnaires' disease in Glasgow, Scotland: application of statistical modelling. Epidemiology and Infection 141(4): 687-696

Meteorological conditions and the diagnosis of occupationally related contact sensitizations. Scandinavian Journal of Work, Environment & Health 34(4): 316-321

Meteorological conditions related to the onset of idiopathic sudden sensorineural hearing loss. Yonsei Medical Journal 55(6): 1678-1682

Meteorological conditions related to the onset of spontaneous pneumothorax. Tohoku Journal of Experimental Medicine 217(4): 329-334

Meteorological conditions, research. Higiene Y Salubridad 14(2): 8-12

Meteorological data analysis using MapReduce. Thescientificworldjournal 2014: 646497-646497

Meteorological effects on the daily activity patterns of tabanid biting flies in northern Queensland, Australia. Medical and Veterinary Entomology 25(1): 17-24

Meteorological factors affecting behaviour. Journal of the Royal Society of Medicine 76(1): 84-85

Meteorological factors and El Nino Southern Oscillation are associated with paediatric varicella infections in Hong Kong, 2004-2010. Epidemiology and Infection 142(7): 1384-1392

Meteorological factors and El Niño Southern Oscillation are independently associated with dengue infections. Epidemiology and Infection 140(7): 1244-1251

Meteorological factors and aneurysmal subarachnoid haemorrhage in Hong Kong. Hong Kong Medical Journal 15(2): 85-89

Meteorological factors and psychiatric emergencies. Actas Espanolas de Psiquiatria 37(1): 34-41

Meteorological factors and risk of community-acquired Legionnaires' disease in Switzerland: an epidemiological study. Bmj Open 3(3): -

Meteorological factors and risk of scrub typhus in Guangzhou, southern China, 2006-2012. Bmc Infectious Diseases 14(): 139-139

Meteorological factors and timing of the initiating event of human parturition. International Journal of Biometeorology 55(2): 265-272

Meteorological factors are associated with hemorrhagic fever with renal syndrome in Jiaonan County, China, 2006-2011. International Journal of Biometeorology 58(6): 1031-1037

Meteorological factors controlling soil gases and indoor CO2 concentration: a permanent risk in degassing areas. Science of the Total Environment 407(4): 1362-1372

Meteorological factors, aeroallergens and asthma-related visits in Kuwait: a 12-month retrospective study. Annals of Saudi Medicine 28(6): 435-441

Meteorological factors-based spatio-temporal mapping and predicting malaria in central China. American Journal of Tropical Medicine and Hygiene 85(3): 560-567

Meteorological influence on aerosol extinction in the 0.2-40-microm wavelength range. Applied Optics 18(20): 3457-3473

Meteorological influence on predicting surface SO2 concentration from satellite remote sensing in Shanghai, China. Environmental Monitoring and Assessment 186(5): 2895-2906

Meteorological influence on sound propagation between adjacent city canyons: a real-life experiment. Journal of the Acoustical Society of America 127(6): 3335-3346

Meteorological influences on stemflow generation across diameter size classes of two morphologically distinct deciduous species. International Journal of Biometeorology 58(10): 2059-2069

Meteorological influences on the incidence of aneurysmal subarachnoid hemorrhage - a single center study of 511 patients. Plos One 8(12): E81621-E81621

Meteorological influences on the incidence of lichen planus in a north Indian population. Journal of Oral Science 55(4): 311-318

Meteorological influences on the seasonality of Lyme disease in the United States. American Journal of Tropical Medicine and Hygiene 90(3): 486-496

Meteorological input data requirements to predict cross-pollination of GMO maize with Lagrangian approaches. Environmental Biosafety Research 5(3): 151-168

Meteorological parameters and seasonal variations in pulmonary thromboembolism. American Journal of Emergency Medicine 26(9): 1035-1041

Meteorological parameters and severity of acute pulmonary embolism episodes. Annals of Agricultural and Environmental Medicine 18(1): 127-130

Meteorological parameters and the onset of chest pain in subjects with acute ST-elevation myocardial infarction: an eight-year, single-center study in China. Cellular Physiology and Biochemistry 34(5): 1589-1596

Meteorological risk factors of stroke. Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 113(9 Pt 2): 28-32

Meteorological variables affect fertility rate after intrauterine artificial insemination in sheep in a seasonal-dependent manner: a 7-year study. International Journal of Biometeorology 59(5): 585-592

Meteorological variables and bacillary dysentery cases in Changsha City, China. American Journal of Tropical Medicine and Hygiene 90(4): 697-704

Meteorological variables and malaria in a Chinese temperate city: A twenty-year time-series data analysis. Environment International 36(5): 439-445

Meteorological variables do not explain the North-South gradient in mortality from multiple sclerosis in Spain. Gaceta Sanitaria 21(4): 329-333

Meteorological variation of atmospheric optical properties in an antarctic storm. Applied Optics 25(7): 1155-1155

Meteorological variations of PM2.5/PM10 concentrations and particle-associated polycyclic aromatic hydrocarbons in the atmospheric environment of Zonguldak, Turkey. Journal of Hazardous Materials 170(1): 13-21

Meteorological, environmental remote sensing and neural network analysis of the epidemiology of malaria transmission in Thailand. Geospatial Health 1(1): 71-84

Meteorologically estimated exposure but not distance predicts asthma symptoms in schoolchildren in the environs of a petrochemical refinery: a cross-sectional study. Environmental Health 8(): 45-45

Meteorologically-driven circulation and flushing times of the Bay of Algeciras, Strait of Gibraltar. Marine Pollution Bulletin 80(1-2): 97-106

Meteorologische Zeitschrift. Science 54(1409): 663-664

Meteorologists have discovered liquid water in cirrus clouds at temperatures [minus ]35 degrees to [minus ]36 degrees C. Applied Optics 23(14): 2281-2281

Meteorology. Science 9(234): 871-872

Meteorology. Science 142(3590): 416-416

Meteorology And The Trans-Atlantic Flight. Science 50(1283): 114-115

Meteorology At The British Association. Science 18(464): 657-661

Meteorology At The Eighth International Geographic Congress. Science 23(576): 74-76

Meteorology At The Sheffield Meeting Of The British Association. Science 32(823): 458-460

Meteorology In Argentina. Science 15(387): 875-876

Meteorology In California. Science 8(204s): 634-636

Meteorology In South America. Science 6(144): 523-525

Meteorology In The University. Science 2(48): 709-714

Meteorology and Climate of Plymouth. British Medical Journal 2(560): 347-349

Meteorology and Mathematics. Science 17(416): 51-51

Meteorology and ethnicity as critical factors in HRIPT: Comparing responses between Chinese and Indian ethnicities. Regulatory Toxicology and Pharmacology 66(1): 59-65

Meteorology and the human body: two hundred years of history. Orvosi Hetilap 151(27): 1099-1105

Meteorology and the supersonic transport. Science 167(3914): 16-25

Meteorology as a Field of Study. Science 131(3404): 944-944

Meteorology for Non-Science Majors. Science 130(3388): 1600-1604

Meteorology in its Bearing on Health and Disease. British Medical Journal 1(641): 400-402

Meteorology in ruptured abdominal aortic aneurysm: an institutional study and a meta-analysis of published studies reporting atmospheric pressure. International Angiology 33(6): 553-559

Meteorology of Air Pollution: The need to preserve our air resources challenges our understanding of the atmosphere's capacities. Science 146(3648): 1119-1128

Meteorology of Hæmorrhage. Provincial Medical Journal and Retrospect of the Medical Sciences 6(135): 91-92

Meteorology of the lower stratosphere. Proceedings of the Royal Society of Medicine 185(Ser A): 144-175

Meteorology's Frozen Assets. Science 69(1784): 255-259

Meteorology. Heat wave forecasts debut in scorching Australia. Science 343(6171): 587-587

Meteorology. One Sandy forecast a bigger winner than others. Science 338(6108): 736-737

Meteorology. Order from chaos, power from dissipation in planetary flows. Science 317(5837): 449-499

Meteorology. Southern Hemisphere storms pulsate to a 25-day beat, new papers show. Science 343(6171): 588-588

Meteorology. Weather forecasts slowly clearing up. Science 338(6108): 734-737

Meteors, comets and meteoric ionization. Nature 159(4055): 76-78

Meteors: An Unexpected Increase in 1963. Science 146(3650): 1458-1458

Meteospazmil for correction of motor disorders in functional colon diseases. Eksperimental'naia i Klinicheskaia Gastroenterologiia 4): 101-106

Meter In Composition. Science 75(1951): 536-537

Meter Versus Yard. Science 119(3095): 567-568

Meter-long and robust supramolecular strands encapsulated in hydrogel jackets. Angewandte Chemie 51(7): 1553-1557

Metered dose inhaler delivery of treprostinil for the treatment of pulmonary hypertension. Pulmonary Pharmacology & Therapeutics 22(1): 50-56

Metered dose inhaler technique among inner-city asthmatics and its association with asthma medication adherence. Clinical Respiratory Journal 8(4): 397-403

Metered dose inhaler with spacer in children with acute asthma. Indian Pediatrics 45(4): 295-297

Metered dose inhalers versus nebulizers for aerosol bronchodilator delivery for adult patients receiving mechanical ventilation in critical care units. Cochrane Database of Systematic Reviews (): Cd008863-Cd008863

Metered-dose inhaler efficiency enhancement: a case study and novel design. Inhalation Toxicology 22(7): 601-609

Metered-dose inhaler ipratropium bromide in moderate acute asthma in children: A single-blinded randomised controlled trial. Journal of Paediatrics and Child Health 51(2): 192-198

Metered-dose inhaler technique: the effect of two educational interventions delivered in community pharmacy over time. Journal of Asthma 47(3): 251-256

Metered-dose inhaler with spacer instead of nebulizer during the outbreak of severe acute respiratory syndrome in Singapore. Respiratory Care 54(7): 855-860

Metered-dose inhalers: actuators old and new. Expert Opinion on Drug Delivery 4(3): 235-245

Metergoline, pirenperone and pizotifen alter dopamine and 5-hydroxytryptamine synthesis in discrete rat brain nuclei. Neurochemistry International 9(3): 423-429

Metergoline-induced cell death in Candida krusei. Fungal Biology 115(3): 302-309

Metering the capillary-driven flow of fluids in paper-based microfluidic devices. Analytical Chemistry 82(10): 4181-4187

Metformin (alone or with insulin) was as effective as insulin for preventing perinatal complications in gestational diabetes. Acp Journal Club 149(2): 7-7

Metformin (dimethyl-biguanide) induced DNA damage in mammalian cells. Genetics and Molecular Biology 35(1): 153-158

Metformin + saxagliptin for type 2 diabetes. Expert Opinion on PharmacoTherapy 13(1): 139-146

Metformin - mechanisms of action and use for the treatment of type 2 diabetes mellitus. Postepy Higieny i Medycyny Doswiadczalnej 65: 277-285

Metformin 2,500 mg/day in the treatment of obese women with polycystic ovary syndrome and its effect on weight, hormones, and lipid profile. Archives of Gynecology and Obstetrics 282(6): 691-694

Metformin Down-regulates TNF-α Secretion via Suppression of Scavenger Receptors in Macrophages. Immune Network 13(4): 123-132

Metformin Eased Cognitive Impairment Induced by Chronic L-methionine Administration: Potential Role of Oxidative Stress. Current Neuropharmacology 12(2): 186-192

Metformin Improves Insulin Signaling in Obese Rats via Reduced IKKbeta Action in a Fiber-Type Specific Manner. Journal of Obesity 2010: -

Metformin Inhibits Isoproterenol-induced Cardiac Hypertrophy in Mice. Korean Journal of Physiology & Pharmacology 14(6): 377-384

Metformin OK in CKD?. Drug and Therapeutics Bulletin 52(4): 37-37

Metformin Restores Intermediate-Conductance Calcium-Activated K⁺ Channel- and Small-Conductance Calcium-Activated K⁺ Channel-Mediated Vasodilatation Impaired by Advanced Glycation End Products in Rat Mesenteric Artery. [Corrected. Molecular Pharmacology 86(5): 580-591

Metformin Suppresses MHC-Restricted Antigen Presentation by Inhibiting Co-Stimulatory Factors and MHC Molecules in APCs. Biomolecules & Therapeutics 21(1): 35-41

Metformin Trumps insulin in the treatment of gestational diabetes. Medscape Journal of Medicine 10(7): 179-179

Metformin abolishes increased tumor (18)F-2-fluoro-2-deoxy-D-glucose uptake associated with a high energy diet. Cell Cycle 10(16): 2770-2778

Metformin accelerates the growth of BRAF V600E-driven melanoma by upregulating VEGF-A. Cancer Discovery 2(4): 344-355

Metformin accumulation without hyperlactataemia and metformin-induced hyperlactataemia without metformin accumulation. Diabetes & Metabolism 40(3): 220-223

Metformin accumulation: lactic acidosis and high plasmatic metformin levels in a retrospective case series of 66 patients on chronic therapy. Clinical Toxicology 52(2): 129-135

Metformin action in human hepatocytes: coactivation of atypical protein kinase C alters 5'-AMP-activated protein kinase effects on lipogenic and gluconeogenic enzyme expression. Diabetologia 56(11): 2507-2516

Metformin action on AMP-activated protein kinase: a translational research approach to understanding a potential new therapeutic target. Diabetic Medicine 27(10): 1097-1106

Metformin activates AMP kinase through inhibition of AMP deaminase. Journal of Biological Chemistry 286(1): 1-11

Metformin activates an ataxia telangiectasia mutated (ATM)/Chk2-regulated DNA damage-like response. Cell Cycle 10(9): 1499-1501

Metformin added to insulin therapy for type 1 diabetes mellitus in adolescents. Cochrane Database of Systematic Reviews (): Cd006691-Cd006691

Metformin added to intensive insulin therapy reduces plasma levels of glycated but not oxidized low‑density lipoprotein in young patients with type 1 diabetes and obesity in comparison with insulin alone: a pilot study. Polskie Archiwum Medycyny Wewnetrznej 123(10): 526-532

Metformin administration in patients with polycystic ovary syndrome who receive gonadotropins for in vitro fertilization cycles: 10-year experience in a large infertile population. Gynecological Endocrinology 28(2): 81-86

Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia. Gynecological Endocrinology 23(3): 146-152

Metformin administration restores allopregnanolone response to adrenocorticotropic hormone (ACTH) stimulation in overweight hyperinsulinemic patients with PCOS. Gynecological Endocrinology 26(9): 684-689

Metformin administration was associated with a modification of LH, prolactin and insulin secretion dynamics in women with polycystic ovarian syndrome. Gynecological Endocrinology 25(7): 427-434

Metformin affects macrophages' phenotype and improves the activity of glutathione peroxidase, superoxide dismutase, catalase and decreases malondialdehyde concentration in a partially AMPK-independent manner in LPS-stimulated human monocytes/macrophages. Pharmacological Reports 66(3): 418-429

Metformin affects the circadian clock and metabolic rhythms in a tissue-specific manner. Biochimica et Biophysica Acta 1822(11): 1796-1806

Metformin after bariatric surgery--an acid problem. Experimental and Clinical Endocrinology & Diabetes 120(3): 152-153

Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT): from cancer stem cells to aging-associated fibrosis. Cell Cycle 9(22): 4461-4468

Metformin against cancer stem cells through the modulation of energy metabolism: special considerations on ovarian cancer. Biomed Research International 2014: 132702-132702

Metformin aggravates immune-mediated liver injury in mice. Archives of Toxicology 89(3): 437-450

Metformin allergy. Indian Journal of Pharmacology 43(2): 216-217

Metformin also as first choice in patients with normal weight. Has its use increased?. Atencion Primaria 41(6): 324-328

Metformin alters the insulin signaling pathway in ischemic cardiac tissue in a swine model of metabolic syndrome. Journal of Thoracic and Cardiovascular Surgery 145(1): 258-65; Discussion 265-6

Metformin ameliorates hepatic steatosis and inflammation without altering adipose phenotype in diet-induced obesity. Plos One 9(3): E91111-E91111

Metformin ameliorates insulin resistance in L6 rat skeletal muscle cells through upregulation of SIRT3. Chinese Medical Journal 127(8): 1523-1529

Metformin ameliorates methotrexate-induced hepatotoxicity. Journal of Pharmacology & Pharmacotherapeutics 3(3): 248-253

Metformin ameliorates ovariectomy-induced vascular dysfunction in non-diabetic Wistar rats. Clinical Science 127(4): 265-275

Metformin amplifies chemotherapy-induced AMPK activation and antitumoral growth. Clinical Cancer Research 17(12): 3993-4005

Metformin and AMPK: an old drug and a new enzyme in the context of metabolic syndrome. Arquivos Brasileiros de Endocrinologia E Metabologia 52(1): 120-125

Metformin and Alzheimer's disease risk. American Journal of Psychiatry 171(1): 119-119

Metformin and atorvastatin combination further protect the liver in type 2 diabetes with hyperlipidaemia. Diabetes/Metabolism Research and Reviews 27(1): 54-62

Metformin and berberine prevent olanzapine-induced weight gain in rats. Plos One 9(3): E93310-E93310

Metformin and breast cancer risk. Journal of Clinical Oncology 31(7): 973-974

Metformin and cancer. Review of Diabetic Studies 10(4): 228-235

Metformin and cancer in type 2 diabetes. Diabetes & Metabolism Journal 37(2): 113-116

Metformin and cancer occurrence in insulin-treated type 2 diabetic patients. Diabetes Care 34(1): 129-131

Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders. Cancer Prevention Research 7(9): 867-885

Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis. Cancer Prevention Research 3(11): 1451-1461

Metformin and cancer stem cells: old drug, new targets. Cancer Prevention Research 5(3): 351-354

Metformin and cancer therapy. Current Opinion in Oncology 24(1): 103-108

Metformin and cancer: doses, mechanisms and the dandelion and hormetic phenomena. Cell Cycle 9(6): 1057-1064

Metformin and cancer: licence to heal?. Expert Opinion on Investigational Drugs 19(8): 913-917

Metformin and cancer: mounting evidence against an association. Diabetes Care 37(7): 1786-1788

Metformin and cancer: new applications for an old drug. Medical Oncology 29(2): 1314-1327

Metformin and colorectal cancer risk in diabetic patients. Diabetes Care 34(10): 2336-2337

Metformin and contrast media. Radiology 256(2): 672-3; Author Reply 673

Metformin and digestive disorders. Diabetes & Metabolism 37(2): 90-96

Metformin and energy metabolism in breast cancer: from insulin physiology to tumour-initiating stem cells. Current Molecular Medicine 10(7): 674-691

Metformin and erlotinib synergize to inhibit basal breast cancer. Oncotarget 5(21): 10503-10517

Metformin and glitazones: do they really help PCOS patients?. Journal of Family Practice 56(6): 444-453

Metformin and gonadotropins for ovulation induction in patients with polycystic ovary syndrome: a systematic review with meta-analysis of randomized controlled trials. Reproductive Biology and Endocrinology 12: 3-3

Metformin and gynecologic cancers. Obstetrical & Gynecological Survey 69(8): 477-489

Metformin and heart failure: never say never again. Expert Opinion on PharmacoTherapy 13(1): 1-8

Metformin and human uterine contractility. Endocrine 42(3): 761-763

Metformin and improvement of the hepatic insulin resistance index independent of anthropometric changes. Endocrine Practice 18(1): 8-16

Metformin and incident breast cancer among diabetic women: a population-based case-control study in Denmark. Cancer Epidemiology, Biomarkers & Prevention 20(1): 101-111

Metformin and incretin-based therapies up-regulate central and peripheral Adenosine monophosphate-activated protein affecting appetite and metabolism. Indian Journal of Endocrinology and Metabolism 16(Suppl 3): S529-S531

Metformin and insomnia: an interesting story. Diabetes & Metabolic Syndrome 5(3): 160-160

Metformin and insulin in chronic heart failure: contraindications not contraindicated and indications not indicated. Giornale Italiano di Cardiologia 12(12): 796-803

Metformin and insulin meet in a most atypical way. Cell Metabolism 9(6): 485-487

Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein. Cell 137(4): 635-646

Metformin and its clinical use: new insights for an old drug in clinical practice. Archives of Medical Science 8(5): 907-917

Metformin and kidneys. Vnitrni Lekarstvi 54(5): 535-540

Metformin and lactic acidosis. British Journal of Anaesthesia 101(6): 876-877

Metformin and lactic acidosis. Acta Clinica Belgica 66(5): 329-331

Metformin and lactic acidosis in an Australian community setting: the Fremantle Diabetes Study. Medical Journal of Australia 188(8): 446-449

Metformin and lactic acidosis in patients with type 2 diabetes--from pride and prejudice to sense and sensibility. Acta Clinica Belgica 64(1): 42-48

Metformin and lactic acidosis. Metformin: framed again?. Bmj 339: B5570-B5570

Metformin and lactic acidosis. NSAIDs and renin-angiotensin-aldosterone system. Bmj 339: B5567-B5567

Metformin and lifestyle changes help people taking antipsychotics lose weight. Harvard Mental Health Letter 24(10): 7-7

Metformin and lifestyle changes reduce antipsychotic-related weight gain in adults with schizophrenia. Evidence-Based Mental Health 11(3): 82-82

Metformin and liraglutide ameliorate high glucose-induced oxidative stress via inhibition of PKC-NAD(P)H oxidase pathway in human aortic endothelial cells. Atherosclerosis 232(1): 156-164

Metformin and low levels of thyroid-stimulating hormone in patients with type 2 diabetes mellitus. Cmaj 186(15): 1138-1145

Metformin and male reproduction: effects on Sertoli cell metabolism. British Journal of Pharmacology 171(4): 1033-1042

Metformin and mortality. Diabetologia 56(4): 937-938

Metformin and mortality. Reply to Lund SS [letter. Diabetologia 56(4): 939-940

Metformin and oral contraceptive treatments reduced circulating asymmetric dimethylarginine (ADMA) levels in patients with polycystic ovary syndrome (PCOS). Atherosclerosis 200(2): 336-344

Metformin and other biguanides in oncology: advancing the research agenda. Cancer Prevention Research 3(9): 1060-1065

Metformin and other insulin sensitizers in polycystic ovary syndrome. Seminars in Reproductive Medicine 32(4): 323-330

Metformin and pancreatic cancer: a clue requiring investigation. Clinical Cancer Research 18(10): 2723-2725

Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer. Journal of Clinical Oncology 27(20): 3297-3302

Metformin and phenethyl isothiocyanate combined treatment in vitro is cytotoxic to ovarian cancer cultures. Journal of Ovarian Research 5(1): 19-19

Metformin and phenformin deplete tricarboxylic acid cycle and glycolytic intermediates during cell transformation and NTPs in cancer stem cells. Proceedings of the National Academy of Sciences of the United States of America 111(29): 10574-9

Metformin and placebo therapy both improve weight management and fasting insulin in obese insulin-resistant adolescents: a prospective, placebo-controlled, randomized study. European Journal of Endocrinology 163(4): 585-592

Metformin and polycystic ovary syndrome. Current Opinion in Endocrinology, Diabetes, and Obesity 14(2): 132-140

Metformin and prognosis of critical illness: a question of timing?. Critical Care 17(6): 471-471

Metformin and rapamycin are master-keys for understanding the relationship between cell senescent, aging and cancer. Aging 5(5): 337-338

Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cells. Breast Cancer Research and Treatment 123(1): 271-279

Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease. Liver International 30(5): 750-758

Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis. Scandinavian Journal of Gastroenterology 48(1): 78-87

Metformin and renal injury protection. Journal of Renal Injury Prevention 2(3): 91-92

Metformin and reprogramming into iPSCs. Cell Cycle 11(6): 1058-1059

Metformin and respiratory chain complex I: the last piece of the puzzle?. Biochemical Journal 463(3): E3-E5

Metformin and salinomycin as the best combination for the eradication of NSCLC monolayer cells and their alveospheres (cancer stem cells) irrespective of EGFR, KRAS, EML4/ALK and LKB1 status. Oncotarget 5(24): 12877-12890

Metformin and sex: Why suppression of aging may be harmful to young male mice. Aging 2(12): 897-899

Metformin and sleep disorders. Indian Journal of Endocrinology and Metabolism 16 Suppl 1: S63-S64

Metformin and survival in pancreatic cancer: a retrospective cohort study. Pancreas 42(7): 1054-1059

Metformin and the ATM DNA damage response (DDR): accelerating the onset of stress-induced senescence to boost protection against cancer. Aging 3(11): 1063-1077

Metformin and the incidence of cancer in patients with diabetes: a nested case-control study. Diabetes Care 36(9): E155-E156

Metformin and the incidence of prostate cancer in patients with type 2 diabetes. Cancer Epidemiology, Biomarkers & Prevention 20(2): 337-344

Metformin and the intestine. Diabetologia 51(8): 1552-1553

Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro. Anticancer Research 32(5): 1627-1637

Metformin and the promise of geroprotection. Indian Journal of Endocrinology and Metabolism 16(4): 496-498

Metformin and the risk of cancer in type 2 diabetes: methodological challenges and perspectives. Annals of Translational Medicine 2(6): 52-52

Metformin and the risk of cancer: time-related biases in observational studies. Diabetes Care 35(12): 2665-2673

Metformin and the risk of head and neck cancer: a case-control analysis. Diabetes, Obesity & Metabolism 16(11): 1148-1154

Metformin and thyroid: an update. European Thyroid Journal 2(1): 22-28

Metformin and troglitazone in the treatment of female infertility associated with polycystic ovarian syndrome. Jnma; Journal of the Nepal Medical Association 48(176): 335-339

Metformin and type 2 diabetes: the UKPDS experience. Journees Annuelles de Diabetologie de L'hotel-Dieu: 5-11

Metformin and type-2 diabetes mellitus. Atencion Primaria 40(3): 147-153

Metformin and vitamin B 12 deficiency. Tidsskrift for den Norske Laegeforening 127(6): 764; Author Reply 764-764; Author Reply 764

Metformin and vitamin B12 deficiency. Medicina Clinica 135(6): 286-287

Metformin and vitamin B12 deficiency: association and not causation may play a major role in cohort studies. Archives of Internal Medicine 167(7): 730; Author Reply 730-1

Metformin anti-tumor effect via disruption of the MID1 translational regulator complex and AR downregulation in prostate cancer cells. Bmc Cancer 14(): 52-52

Metformin as a Rare Cause of Drug-Induced Liver Injury, a Case Report and Literature Review. American Journal of Therapeutics 23(1): E315-E317

Metformin as a cause of high stomal output. Colorectal Disease 14(2): E77-E77

Metformin as a geroprotector. Rejuvenation Research 14(5): 469-482

Metformin as a key to alternative activation of microglia?. Postepy Higieny i Medycyny Doswiadczalnej 68: 247-257

Metformin as a treatment for antipsychotic drug side effects: special focus on women with schizophrenia. American Journal of Psychiatry 169(8): 774-776

Metformin as a weight-loss tool in "at-risk" obese adolescents: a magic bullet?. Journal of Pediatrics 152(6): 750-752

Metformin as adjunct antituberculosis therapy. Science Translational Medicine 6(263): 263ra159-263ra159

Metformin as adjuvant therapy to IVF in women with PCOS: when is intention-to-treat unintentional?. Human Reproduction 26(8): 2043-2044

Metformin as an addition to conventional chemotherapy in breast cancer. Journal of Clinical Oncology 27(35): E259; Author Reply E260-E259; Author Reply E260

Metformin as an adjunct to insulin for glycemic control in patients with type 2 diabetes after CABG surgery: a randomized double blind clinical trial. Pakistan Journal of Biological Sciences 14(23): 1047-1054

Metformin as an adjuvant drug against pediatric sarcomas: hypoxia limits therapeutic effects of the drug. Plos One 8(12): E83832-E83832

Metformin as an antitumor agent in cancer prevention and treatment. Journal of Diabetes 3(4): 320-327

Metformin as an energy restriction mimetic agent for breast cancer prevention. Journal of Carcinogenesis 10(): 17-17

Metformin as first choice in oral diabetes treatment: the UKPDS experience. Journees Annuelles de Diabetologie de L'hotel-Dieu: 13-20

Metformin as the first line antidiabetic agent. Vnitrni Lekarstvi 56(12): 1225-1227

Metformin associated B12 deficiency. Journal of the Association of Physicians of India 60: 58-60

Metformin associated lactic acidosis not as rare as we think:. Acute Medicine 5(3): 99-101

Metformin associated lactic acidosis: incidence and clinical correlation with metformin serum concentration measurements. Journal of Clinical Pharmacy and Therapeutics 36(3): 376-382

Metformin associated with better cardiovascular outcomes than other glycaemic therapies. Evidence-Based Medicine 19(3): 103-103

Metformin associated with lactic acidosis in treatment of type 2 diabetes. Ugeskrift for Laeger 174(23): 1598-1602

Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16. Diabetes Care 33(2): 322-326

Metformin associated with lower mortality in diabetic patients with early stage hepatocellular carcinoma after radiofrequency ablation. Journal of Gastroenterology and Hepatology 26(5): 858-865

Metformin associated with photodynamic therapy--a novel oncological direction. Journal of Photochemistry and Photobiology. B, Biology 138: 80-91

Metformin associates lactic acidosis. Presse Medicale 41(10): 907-916

Metformin attenuated the autoimmune disease of the central nervous system in animal models of multiple sclerosis. Journal of Immunology 182(12): 8005-8014

Metformin attenuates Alzheimer's disease-like neuropathology in obese, leptin-resistant mice. Pharmacology, Biochemistry, and Behavior 101(4): 564-574

Metformin attenuates blood-brain barrier disruption in mice following middle cerebral artery occlusion. Journal of Neuroinflammation 11(): 177-177

Metformin attenuates cardiac fibrosis by inhibiting the TGFbeta1-Smad3 signalling pathway. Cardiovascular Research 87(3): 504-513

Metformin attenuates experimental autoimmune arthritis through reciprocal regulation of Th17/Treg balance and osteoclastogenesis. Mediators of Inflammation 2014: 973986-973986

Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner. Journal of Cellular and Molecular Medicine 15(1): 166-178

Metformin attenuates palmitate-induced endoplasmic reticulum stress, serine phosphorylation of IRS-1 and apoptosis in rat insulinoma cells. Plos One 9(6): E97868-E97868

Metformin attenuates production of nitric oxide in response to lipopolysaccharide by inhibiting MyD88-independent pathway. Hormone and Metabolic Research 42(9): 632-636

Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression. Chemico-Biological Interactions 192(3): 233-242

Metformin attenuates the exacerbation of the allergic eosinophilic inflammation in high fat-diet-induced obesity in mice. Plos One 8(10): E76786-E76786

Metformin attenuates the stimulatory effect of a high-energy diet on in vivo LLC1 carcinoma growth. Endocrine-Related Cancer 15(3): 833-839

Metformin attenuates ventricular hypertrophy by activating the AMP-activated protein kinase-endothelial nitric oxide synthase pathway in rats. Clinical and Experimental Pharmacology & Physiology 38(1): 55-62

Metformin augments the levels of molecules that regulate the expression of the insulin-dependent glucose transporter GLUT4 in the endometria of hyperinsulinemic PCOS patients. Human Reproduction 28(8): 2235-2244

Metformin based dual-combination therapies in drug naïve type 2 diabetic patients. Diabetes & Metabolism Journal 37(6): 429-432

Metformin before and during pregnancy and lactation in polycystic ovary syndrome. Expert Opinion on Drug Safety 6(2): 191-198

Metformin beyond diabetes: new life for an old drug. Current Diabetes Reviews 2(3): 307-315

Metformin blocks melanoma invasion and metastasis development in AMPK/p53-dependent manner. Molecular Cancer Therapeutics 12(8): 1605-1615

Metformin blocks migration and invasion of tumour cells by inhibition of matrix metalloproteinase-9 activation through a calcium and protein kinase Calpha-dependent pathway: phorbol-12-myristate-13-acetate-induced/extracellular signal-regulated kinase/activator protein-1. British Journal of Pharmacology 160(5): 1195-1211

Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase. Endocrine-Related Cancer 17(2): 351-360

Metformin can activate imidazoline I-2 receptors to lower plasma glucose in type 1-like diabetic rats. Hormone and Metabolic Research 43(1): 26-30

Metformin causes nitric oxide-mediated dilatation in a shorter time than insulin in the iliac artery of the anesthetized pig. Journal of Cardiovascular Pharmacology 59(2): 182-187

Metformin causing vitamin B12 deficiency: a guilty verdict without sufficient evidence. Diabetes Care 37(2): E22-E23

Metformin combined with p38 MAPK inhibitor improves cisplatin sensitivity in cisplatin‑resistant ovarian cancer. Molecular Medicine Reports 10(5): 2346-2350

Metformin compared with glyburide for the management of gestational diabetes. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 111(1): 37-40

Metformin compared with glyburide in gestational diabetes: a randomized controlled trial. Obstetrics and Gynecology 115(1): 55-59

Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology 30(6): 483-490

Metformin counters both lipolytic/inflammatory agents-decreased hormone sensitive lipase phosphorylation at Ser-554 and -induced lipolysis in human adipocytes. Archives of Physiology and Biochemistry 117(4): 209-214

Metformin decreases GnRH- and activin-induced gonadotropin secretion in rat pituitary cells: potential involvement of adenosine 5' monophosphate-activated protein kinase (PRKA). Biology of Reproduction 84(2): 351-362

Metformin decreases IGF1-induced cell proliferation and protein synthesis through AMP-activated protein kinase in cultured bovine granulosa cells. Reproduction 139(2): 409-418

Metformin decreases IL-22 secretion to suppress tumor growth in an orthotopic mouse model of hepatocellular carcinoma. International Journal of Cancer 136(11): 2556-2565

Metformin decreases angiogenesis via NF-kappaB and Erk1/2/Erk5 pathways by increasing the antiangiogenic thrombospondin-1. Cardiovascular Research 83(3): 566-574

Metformin decreases circulating acylation-stimulating protein levels in polycystic ovary syndrome. Gynecological Endocrinology 23(12): 710-715

Metformin decreases circulating androgen and estrogen levels in nondiabetic women with breast cancer. Clinical Breast Cancer 13(6): 433-438

Metformin decreases glucose oxidation and increases the dependency of prostate cancer cells on reductive glutamine metabolism. Cancer Research 73(14): 4429-4438

Metformin decreases glycated albumin to glycated haemoglobin ratio in patients with newly diagnosed type 2 diabetes. Annals of Clinical Biochemistry 52(Pt 1): 76-81

Metformin decreases high-fat diet-induced renal injury by regulating the expression of adipokines and the renal AMP-activated protein kinase/acetyl-CoA carboxylase pathway in mice. International Journal of Molecular Medicine 32(6): 1293-1302

Metformin decreases lung cancer risk in diabetic patients in a dose-dependent manner. Lung Cancer 86(2): 137-143

Metformin decreases plasma resistin concentrations in pediatric patients with impaired glucose tolerance: a placebo-controlled randomized clinical trial. Metabolism: Clinical and Experimental 61(9): 1247-1255

Metformin decreases the incidence of ovarian hyperstimulation syndrome: an experimental study. Journal of Ovarian Research 6(1): 62-62

Metformin decreases thyrotropin in overweight women with polycystic ovarian syndrome and hypothyroidism. Diabetes & Vascular Disease Research 8(1): 47-48

Metformin differentially activates ER stress signaling pathways without inducing apoptosis. Disease Models & Mechanisms 5(2): 259-269

Metformin directly acts on mitochondria to alter cellular bioenergetics. Cancer & Metabolism 2(): 12-12

Metformin discontinuation rate among patients with type-2 diabetes mellitus in Basrah, Iraq. Saudi Medical Journal 28(12): 1919-1921

Metformin dispersible tablets: line extension. A welcome formulation of an essential drug. Prescrire International 17(96): 138-138

Metformin displays anti-myeloma activity and synergistic effect with dexamethasone in in vitro and in vivo xenograft models. Cancer Letters 356(2 Pt B): 443-453

Metformin disrupts crosstalk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth. Cancer Research 69(16): 6539-6545

Metformin does not affect cancer risk: a cohort study in the U.K. Clinical Practice Research Datalink analyzed like an intention-to-treat trial. Diabetes Care 37(9): 2522-2532

Metformin does not attenuate the acute insulin-sensitizing effect of a single bout of exercise in individuals with insulin resistance. Acta Diabetologica 51(5): 749-755

Metformin does not harm diabetic patients with heart failure. Journal of Family Practice 56(12): 996-996

Metformin does not improve survival in patients with hepatocellular carcinoma. World Journal of Gastroenterology 20(42): 15750-5

Metformin does not improve the reproductive or metabolic profile in women with polycystic ovary syndrome (PCOS). Reproductive Sciences 16(10): 938-946

Metformin does not reduce markers of cell proliferation in esophageal tissues of patients with Barrett's esophagus. Clinical Gastroenterology and Hepatology 13(4): 665-72.E1-4

Metformin does not suppress the aromatase expression in breast cancer tissue of patients with concurrent type 2 diabetes. Voprosy Onkologii 58(2): 194-198

Metformin does not suppress thyrotropin. Endocrine Practice 14(2): 252-253

Metformin downregulates the insulin/IGF-I signaling pathway and inhibits different uterine serous carcinoma (USC) cells proliferation and migration in p53-dependent or -independent manners. Plos One 8(4): E61537-E61537

Metformin during pregnancy in polycystic ovary syndrome: another vitamin bites the dust. Journal of Clinical Endocrinology and Metabolism 95(12): 5199-5202

Metformin effect on urethane-induced tumorigenesis in mice. Voprosy Onkologii 58(4): 549-553

Metformin effects on clomifene-induced ovulation in the polycystic ovary syndrome. La Tunisie Medicale 87(1): 43-49

Metformin effects on malignant cells and healthy PBMC; the influence of metformin on the phenotype of breast cancer cells. Pathology Oncology Research 21(3): 605-612

Metformin effects on ovarian ultrasound appearance and steroidogenic function in normal-weight normoinsulinemic women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial. Fertility and Sterility 93(7): 2303-2310

Metformin effects revisited. Diabetes Research and Clinical Practice 95(1): 1-9

Metformin effects upon blood pressure and glucose metabolism of monossodium glutamate induced-obese spontaneously hypertensive rats. Arquivos Brasileiros de Endocrinologia E Metabologia 53(4): 409-415

Metformin efficiency for the adolescent PCOS treatment. Akusherstvo i Ginekologiia 51(6): 6-10

Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway. American Journal of Respiratory Cell and Molecular Biology 49(2): 241-250

Metformin enhances glucagon-like peptide 1 via cooperation between insulin and Wnt signaling. Journal of Endocrinology 220(2): 117-128

Metformin enhances nitric oxide production and diminishes Rho kinase activity in rats with hyperlipidemia. Lipids in Health and Disease 13(): 115-115

Metformin enhances tamoxifen-mediated tumor growth inhibition in ER-positive breast carcinoma. Bmc Cancer 14(): 172-172

Metformin enhances the differentiation and mineralization of osteoblastic MC3T3-E1 cells via AMP kinase activation as well as eNOS and BMP-2 expression. Biochemical and Biophysical Research Communications 375(3): 414-419

Metformin exaggerates phenylephrine-induced AMPK phosphorylation independent of CaMKKβ and attenuates contractile response in endothelium-denuded rat aorta. Biochemical Pharmacology 92(2): 266-279

Metformin exhibits radiation countermeasures efficacy when used alone or in combination with sulfhydryl containing drugs. Radiation Research 181(5): 464-470

Metformin exposure affects human and mouse fetal testicular cells. Human Reproduction 27(11): 3304-3314

Metformin exposure and disseminated disease in patients with colorectal cancer. Cancer Epidemiology 38(1): 79-84

Metformin exposure at environmentally relevant concentrations causes potential endocrine disruption in adult male fish. Environmental Toxicology and Chemistry 34(2): 291-296

Metformin extended release treatment of adolescent obesity: a 48-week randomized, double-blind, placebo-controlled trial with 48-week follow-up. Archives of Pediatrics & Adolescent Medicine 164(2): 116-123

Metformin extends life span of HER-2/neu transgenic mice and in combination with melatonin inhibits growth of transplantable tumors in vivo. Cell Cycle 9(1): 188-197

Metformin for aging and cancer prevention. Aging 2(11): 760-774

Metformin for antipsychotic-related weight gain and metabolic abnormalities: when, for whom, and for how long?. American Journal of Psychiatry 170(9): 947-952

Metformin for atypical antipsychotic-induced weight gain and glucose metabolism dysregulation: review of the literature and clinical suggestions. Cns Drugs 24(3): 193-206

Metformin for cancer prevention. Frontiers of Medicine 5(2): 115-117

Metformin for cardiovascular disease: promise still unproven. Lancet. Diabetes & Endocrinology 2(2): 94-95

Metformin for castrate-resistant prostate cancer: learning more about an old dog's new tricks. European Urology 66(3): 475-7; Discussion 477-8

Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial. Lancet. Diabetes & Endocrinology 2(2): 116-124

Metformin for obesity in children and adolescents: a systematic review. Diabetes Care 32(9): 1743-1745

Metformin for olanzapine-induced weight gain: a systematic review and meta-analysis. British Journal of Clinical Pharmacology 71(3): 377-382

Metformin for overweight women at midlife: a double-blind, randomized, controlled trial. Climacteric 18(2): 270-277

Metformin for polycystic ovary syndrome. Endokrynologia Polska 64(5): 409-414

Metformin for primary colorectal cancer prevention in patients with diabetes: a case-control study in a US population. Cancer 121(7): 1071-1078

Metformin for schizophrenia: an editorial comment to Curtis J, Newall H, Shiers D, Samaras K. 'Considering metformin in cardiometabolic protection in psychosis'. Acta Psychiatrica Scandinavica 126(4): 233-234

Metformin for the prevention of androgen deprivation induced metabolic syndrome, obesity and type 2 diabetes. Medical Hypotheses 72(2): 227-228

Metformin for the treatment of hyperandrogenism in adolescents with type 1 diabetes mellitus. Hormone Research in Paediatrics 80(5): 343-349

Metformin for the treatment of the polycystic ovary syndrome. New England Journal of Medicine 358(1): 47-54

Metformin for treatment of antipsychotic-induced amenorrhea and weight gain in women with first-episode schizophrenia: a double-blind, randomized, placebo-controlled study. American Journal of Psychiatry 169(8): 813-821

Metformin for treatment of antipsychotic-induced weight gain: a randomized, placebo-controlled study. Schizophrenia Research 138(1): 54-57

Metformin for weight control in pediatric patients on atypical antipsychotic medication. Journal of Child and Adolescent Psychopharmacology 19(3): 275-279

Metformin for weight loss and control in patients with mood disorder. Journal of Clinical Psychiatry 75(10): E1140-1

Metformin for weight loss and metabolic control in overweight outpatients with schizophrenia and schizoaffective disorder. American Journal of Psychiatry 170(9): 1032-1040

Metformin for weight loss in schizophrenia: safe but not a panacea. Evidence-Based Mental Health 17(2): 51-52

Metformin for weight reduction in non-diabetic patients on antipsychotic drugs: a systematic review and meta-analysis. Journal of Psychopharmacology 25(3): 299-305

Metformin has adenosine-monophosphate activated protein kinase (AMPK)-independent effects on LPS-stimulated rat primary microglial cultures. Pharmacological Reports 62(5): 827-848

Metformin has no major effects on glucose homeostasis in pregnant women with PCOS: results of a randomized double-blind study. Scandinavian Journal of Clinical and Laboratory Investigation 68(8): 771-776

Metformin has wider implications than diabetes. Post Reproductive Health 20(3): 89-89

Metformin high dosage and bleeding episode: A clinical case study. Indian Journal of Endocrinology and Metabolism 15(2): 132-133

Metformin hydrochloride-loaded poly(vinyl alcohol) composites as drug delivery systems. Journal of Nanoscience and Nanotechnology 11(10): 8621-8627

Metformin impairs Rho GTPase signaling to induce apoptosis in neuroblastoma cells and inhibits growth of tumors in the xenograft mouse model of neuroblastoma. Oncotarget 5(22): 11709-11722

Metformin impairs growth of endometrial cancer cells via cell cycle arrest and concomitant autophagy and apoptosis. Cancer Cell International 14(): 53-53

Metformin impairs mitochondrial function in skeletal muscle of both lean and diabetic rats in a dose-dependent manner. Plos One 9(6): E100525-E100525

Metformin impairs vascular endothelial recovery after stent placement in the setting of locally eluted mammalian target of rapamycin inhibitors via S6 kinase-dependent inhibition of cell proliferation. Journal of the American College of Cardiology 61(9): 971-980

Metformin improves cardiac function in rats via activation of AMP-activated protein kinase. Clinical and Experimental Pharmacology & Physiology 38(2): 94-101

Metformin improves endothelial function in normoinsulinemic PCOS patients: a new prospective. Human Reproduction 23(9): 2127-2133

Metformin improves epididymal sperm quality and antioxidant function of the testis in diet-induced obesity rats. Zhonghua Nan Ke Xue 18(2): 146-149

Metformin improves glucose effectiveness, not insulin sensitivity: predicting treatment response in women with polycystic ovary syndrome in an open-label, interventional study. Journal of Clinical Endocrinology and Metabolism 99(5): 1870-1878

Metformin improves immunosuppressant induced hyperglycemia and exocrine apoptosis in rats. Transplantation 95(2): 280-284

Metformin improves postprandial glucose homeostasis in rainbow trout fed dietary carbohydrates: a link with the induction of hepatic lipogenic capacities?. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 297(3): R707-R715

Metformin improves semen characteristics of oligo-terato-asthenozoospermic men with metabolic syndrome. Fertility and Sterility 95(6): 2150-2152

Metformin improves skin flap survival through nitric oxide system. Journal of Surgical Research 192(2): 686-691

Metformin improves survival in intensive care unit patients, but why?. Critical Care 17(6): 471-471

Metformin improves sustained virologic response in difficult-to-cure hepatitis C: more questions than answers. Hepatology 51(3): 1082; Author Reply 1082-3

Metformin in Diabetic Patients with Heart Failure: Safe and Effective?. Current Cardiovascular Risk Reports 7(6): 417-422

Metformin in adolescents and adults with type 1 diabetes mellitus: not evidence-based. Nederlands Tijdschrift Voor Geneeskunde 155(39): A3166-A3166

Metformin in breast cancer: time for action. Journal of Clinical Oncology 27(20): 3271-3273

Metformin in cancer prevention and therapy. Annals of Translational Medicine 2(6): 57-57

Metformin in cancer therapy: a new perspective for an old antidiabetic drug?. Molecular Cancer Therapeutics 9(5): 1092-1099

Metformin in cancer treatment and prevention. Annual Review of Medicine 66: 17-29

Metformin in chemically-induced mammary carcinogenesis in rats. Neoplasma 56(3): 269-274

Metformin in chemotherapy-naive castration-resistant prostate cancer: a multicenter phase 2 trial (SAKK 08/09). European Urology 66(3): 468-474

Metformin in chronic hepatitis C virus hepatitis: caution needed with sex-based subgroup analysis. Hepatology 51(2): 719-719

Metformin in chronic kidney disease: time for a rethink. Peritoneal Dialysis International 34(4): 353-357

Metformin in combination with structured lifestyle intervention improved body mass index in obese adolescents, but did not improve insulin resistance. Endocrine 36(1): 141-146

Metformin in equine metabolic syndrome: an enigma or a dead duck?. Veterinary Journal 191(1): 17-18

Metformin in heart failure. Diabetes Care 30(12): E129-E129

Metformin in lung cancer: rationale for a combination therapy. Expert Opinion on Investigational Drugs 22(11): 1401-1409

Metformin in non-alcoholic fatty liver disease: A systematic review and meta-analysis. Biomedical Reports 1(1): 57-64

Metformin in nonalcoholic steatohepatitis: a randomized controlled trial. Middle East Journal of Digestive Diseases 4(1): 16-22

Metformin in normal-weight hirsute women with polycystic ovary syndrome with normal insulin sensitivity. Gynecological Endocrinology 23(5): 273-278

Metformin in obesity. Archives of Disease in Childhood 99(3): 231-231

Metformin in obesity, cancer and aging: addressing controversies. Aging 4(5): 320-329

Metformin in patients with chronic kidney disease: strengths and weaknesses. Journal of Nephrology 26(1): 55-60

Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial. Scandinavian Journal of Gastroenterology 44(7): 853-860

Metformin in peritoneal dialysis: a pilot experience. Peritoneal Dialysis International 34(4): 368-375

Metformin in polycystic ovary syndrome. New England Journal of Medicine 358(17): 1866-7; Author Reply 1868

Metformin in polycystic ovary syndrome. Annals of the New York Academy of Sciences 1205: 192-198

Metformin in pregnancy. Ginekologia Polska 85(7): 527-531

Metformin in renal failure--weigh the evidence. Nephrology, Dialysis, Transplantation 24(7): 2287-2288

Metformin in reproductive health, pregnancy and gynaecological cancer: established and emerging indications. Human Reproduction Update 20(6): 853-868

Metformin in serum. Results of a study as basis for preliminary therapeutic recommendations. Lakartidningen 106(7): 428-429

Metformin in the clinical practice. Polish Society of Endocrinology consensus based on the European and American medical societies. Endokrynologia Polska 59(2): 174-179

Metformin in the diabetic brain: friend or foe?. Annals of Translational Medicine 2(6): 54-54

Metformin in the treatment of clomiphene citrate-resistant women with polycystic ovary syndrome undergoing in vitro fertilisation treatment: a randomised controlled trial. Journal of Obstetrics and Gynaecology 29(7): 651-655

Metformin in the treatment of infertility in polycystic ovarian syndrome: an alternative perspective. Fertility and Sterility 90(1): 14-16

Metformin in the treatment of non-alcoholic fatty liver disease: safety, efficacy and mechanism. Expert Review of Gastroenterology & Hepatology 8(4): 343-349

Metformin in the treatment of obese children and adolescents at risk of type 2 diabetes. Paediatric Drugs 16(1): 13-20

Metformin in the treatment of polycystic ovary syndrome. Current Pharmaceutical Design 14(21): 2121-2125

Metformin in type 1 diabetes reduces insulin requirements without significantly improving glycaemic control. Diabetologia 53(10): 2264-2265

Metformin in type 1 diabetes reduces insulin requirements without significantly improving glycaemic control. Reply to Schatz H [letter. Diabetologia 54(1): 203-204

Metformin in type 2 diabetes. An extensive observational study confirms the agent as first choice--so far. Lakartidningen 108(4): 136-136

Metformin in type 2 diabetes: what if we get it wrong?. Presse Medicale 42(2): 132-133

Metformin in vitro and in vivo increases adenosine signaling in rabbit corpora cavernosa. Journal of Sexual Medicine 11(7): 1694-1708

Metformin in women with PCOS, cons. Endocrine 48(2): 428-433

Metformin in women with PCOS, pros. Endocrine 48(2): 422-426

Metformin increases HDL3-cholesterol and decreases subcutaneous truncal fat in nondiabetic patients with HIV-associated lipodystrophy. Aids Patient Care and Stds 22(10): 779-786

Metformin increases fasting plasma peptide tyrosine tyrosine (PYY) in women with polycystic ovarian syndrome (PCOS). Clinical Endocrinology 69(6): 936-942

Metformin increases mitochondrial energy formation in L6 muscle cell cultures. Journal of Biological Chemistry 288(28): 20369-20377

Metformin increases phagocytosis and acidifies lysosomal/endosomal compartments in AMPK-dependent manner in rat primary microglia. Naunyn-Schmiedeberg's Archives of Pharmacology 381(2): 171-186

Metformin increases plasma ghrelin in Type 2 diabetes. British Journal of Clinical Pharmacology 68(6): 875-882

Metformin increases serum concentration of high molecular weight (HMW-adiponectin) in nondiabetic obese subjects. Gaceta Medica de Mexico 150(4): 324-333

Metformin increases the novel adipokine adipolin/CTRP12: role of the AMPK pathway. Journal of Endocrinology 219(2): 101-108

Metformin increases the novel adipokine cartonectin/CTRP3 in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 98(12): E1891-E1900

Metformin induced acute pancreatitis. Dermato-Endocrinology 5(2): 317-318

Metformin induced expression of Hsp60 in human THP-1 monocyte cells. Cell Stress & Chaperones 17(1): 23-28

Metformin induced lactic acidosis--particularities and course. Revista Medico-Chirurgicala A Societatii de Medici Si Naturalisti Din Iasi 117(4): 1035-1042

Metformin induced severe hypophosphatemia in a patient on hemodialysis. Saudi Journal of Kidney Diseases and Transplantation 21(5): 923-926

Metformin induces G1 cell cycle arrest and inhibits cell proliferation in nasopharyngeal carcinoma cells. Anatomical Record 294(8): 1337-1343

Metformin induces PGC-1α expression and selectively affects hepatic PGC-1α functions. British Journal of Pharmacology 171(9): 2351-2363

Metformin induces Rab4 through AMPK and modulates GLUT4 translocation in skeletal muscle cells. Journal of Cellular Physiology 226(4): 974-981

Metformin induces a dietary restriction-like state and the oxidative stress response to extend C. elegans Healthspan via AMPK, LKB1, and SKN-1. Plos One 5(1): E8758-E8758

Metformin induces a prompt decrease in LH-stimulated testosterone response in women with PCOS independent of its insulin-sensitizing effects. Reproductive Biology and Endocrinology 12: 98-98

Metformin induces a senescence-associated gene signature in breast cancer cells. Journal of Health Care for the Poor and Underserved 24(1 Suppl): 93-103

Metformin induces an intracellular reductive state that protects oesophageal squamous cell carcinoma cells against cisplatin but not copper-bis(thiosemicarbazones). Bmc Cancer 14(): 314-314

Metformin induces apoptosis and cell cycle arrest mediated by oxidative stress, AMPK and FOXO3a in MCF-7 breast cancer cells. Plos One 9(5): E98207-E98207

Metformin induces apoptosis in hepatocellular carcinoma Huh-7 cells in vitro and its mechanism. Zhonghua Zhong Liu Za Zhi 35(10): 742-746

Metformin induces apoptosis of lung cancer cells through activating JNK/p38 MAPK pathway and GADD153. Neoplasma 58(6): 482-490

Metformin induces apoptosis of pancreatic cancer cells. World Journal of Gastroenterology 14(47): 7192-7198

Metformin induces apoptosis through AMPK-dependent inhibition of UPR signaling in ALL lymphoblasts. Plos One 8(8): E74420-E74420

Metformin induces cytotoxicity by down-regulating thymidine phosphorylase and excision repair cross-complementation 1 expression in non-small cell lung cancer cells. Basic & Clinical Pharmacology & Toxicology 113(1): 56-65

Metformin induces differentiation in acute promyelocytic leukemia by activating the MEK/ERK signaling pathway. Biochemical and Biophysical Research Communications 422(3): 398-404

Metformin induces lactate production in peripheral blood mononuclear cells and platelets through specific mitochondrial complex I inhibition. Acta Physiologica 213(1): 171-180

Metformin induces microRNA-34a to downregulate the Sirt1/Pgc-1α/Nrf2 pathway, leading to increased susceptibility of wild-type p53 cancer cells to oxidative stress and therapeutic agents. Free Radical Biology & Medicine 74: 21-34

Metformin induces osteoblast differentiation via orphan nuclear receptor SHP-mediated transactivation of Runx2. Bone 48(4): 885-893

Metformin induces oxidative stress in white adipocytes and raises uncoupling protein 2 levels. Journal of Endocrinology 199(1): 33-40

Metformin induces reductions in plasma cobalamin and haptocorrin bound cobalamin levels in elderly diabetic patients. Clinical Biochemistry 43(9): 759-760

Metformin induces renal medullary interstitial cell apoptosis in type 2 diabetic mice. Journal of Diabetes 6(2): 132-146

Metformin induces suppression of NAD(P)H oxidase activity in podocytes. Biochemical and Biophysical Research Communications 393(2): 268-273

Metformin induces unique biological and molecular responses in triple negative breast cancer cells. Cell Cycle 8(13): 2031-2040

Metformin influence on hormone levels at birth, in PCOS mothers and their newborns. Human Reproduction 25(3): 786-790

Metformin inhibition of mTORC1 activation, DNA synthesis and proliferation in pancreatic cancer cells: dependence on glucose concentration and role of AMPK. Biochemical and Biophysical Research Communications 430(1): 352-357

Metformin inhibition of neuroblastoma cell proliferation is differently modulated by cell differentiation induced by retinoic acid or overexpression of NDM29 non-coding RNA. Cancer Cell International 14(): 59-59

Metformin inhibits HMGB1 release in LPS-treated RAW 264.7 cells and increases survival rate of endotoxaemic mice. British Journal of Pharmacology 162(7): 1498-1508

Metformin inhibits P-glycoprotein expression via the NF-κB pathway and CRE transcriptional activity through AMPK activation. British Journal of Pharmacology 162(5): 1096-1108

Metformin inhibits StAR expression in human endometriotic stromal cells via AMPK-mediated disruption of CREB-CRTC2 complex formation. Journal of Clinical Endocrinology and Metabolism 99(8): 2795-2803

Metformin inhibits TNF-alpha-induced IkappaB kinase phosphorylation, IkappaB-alpha degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation. International Journal of Cardiology 134(2): 169-175

Metformin inhibits advanced glycation end products (AGEs)-induced growth and VEGF expression in MCF-7 breast cancer cells by suppressing AGEs receptor expression via AMP-activated protein kinase. Hormone and Metabolic Research 45(5): 387-390

Metformin inhibits advanced glycation end products (AGEs)-induced renal tubular cell injury by suppressing reactive oxygen species generation via reducing receptor for AGEs (RAGE) expression. Hormone and Metabolic Research 44(12): 891-895

Metformin inhibits androgen-induced IGF-IR up-regulation in prostate cancer cells by disrupting membrane-initiated androgen signaling. Endocrinology 155(4): 1207-1221

Metformin inhibits angiogenesis induced by interaction of hepatocellular carcinoma with hepatic stellate cells. Cell Biochemistry and Biophysics 71(2): 931-936

Metformin inhibits angiotensin II-induced differentiation of cardiac fibroblasts into myofibroblasts. Plos One 8(9): E72120-E72120

Metformin inhibits aromatase expression in human breast adipose stromal cells via stimulation of AMP-activated protein kinase. Breast Cancer Research and Treatment 123(2): 591-596

Metformin inhibits aromatase via an extracellular signal-regulated kinase-mediated pathway. Endocrinology 150(10): 4794-4801

Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro. Cell Cycle 8(6): 909-915

Metformin inhibits cell growth by upregulating microRNA-26a in renal cancer cells. International Journal of Clinical and Experimental Medicine 7(10): 3289-3296

Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells. Cancer Prevention Research 5(3): 355-364

Metformin inhibits epithelial-mesenchymal transition in prostate cancer cells: involvement of the tumor suppressor miR30a and its target gene SOX4. Biochemical and Biophysical Research Communications 452(3): 746-752

Metformin inhibits esophagus cancer proliferation through upregulation of USP7. Cellular Physiology and Biochemistry 32(5): 1178-1186

Metformin inhibits expression and secretion of PEDF in adipocyte and hepatocyte via promoting AMPK phosphorylation. Mediators of Inflammation 2013(): 429207-429207

Metformin inhibits food intake and neuropeptide Y gene expression in the hypothalamus. Neural Regeneration Research 8(25): 2379-2388

Metformin inhibits glioma cell U251 invasion by downregulation of fibulin-3. Neuroreport 24(10): 504-508

Metformin inhibits glutaminase activity and protects against hepatic encephalopathy. Plos One 7(11): E49279-E49279

Metformin inhibits growth and sensitizes osteosarcoma cell lines to cisplatin through cell cycle modulation. Oncology Reports 31(1): 370-375

Metformin inhibits growth of eutopic stromal cells from adenomyotic endometrium via AMPK activation and subsequent inhibition of AKT phosphorylation: a possible role in the treatment of adenomyosis. Reproduction 146(4): 397-406

Metformin inhibits growth of hepatocellular carcinoma cells by inducing apoptosis via mitochondrion-mediated pathway. Asian Pacific Journal of Cancer Prevention 13(7): 3275-3279

Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state. Journal of Clinical Investigation 120(7): 2355-2369

Metformin inhibits hepatitis B virus protein production and replication in human hepatoma cells. Journal of Viral Hepatitis 21(8): 597-603

Metformin inhibits histone H2B monoubiquitination and downstream gene transcription in human breast cancer cells. Oncology Letters 8(2): 809-812

Metformin inhibits inflammatory angiogenesis in a murine sponge model. Biomedicine & PharmacoTherapy 64(3): 220-225

Metformin inhibits inflammatory response via AMPK-PTEN pathway in vascular smooth muscle cells. Biochemical and Biophysical Research Communications 425(4): 866-872

Metformin inhibits intracellular lipid accumulation in the murine pre-adipocyte cell line, 3T3-L1. Diabetes, Obesity & Metabolism 10(8): 688-690

Metformin inhibits leptin-induced growth and migration of glioblastoma cells. Oncology Letters 4(5): 1077-1081

Metformin inhibits lung cancer cells proliferation through repressing microRNA-222. Biotechnology Letters 35(12): 2013-2019

Metformin inhibits macrophage cholesterol biosynthesis rate: possible role for metformin-induced oxidative stress. Biochemical and Biophysical Research Communications 439(3): 396-400

Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis. Elife 3: E02242-E02242

Metformin inhibits nuclear factor kappaB activation and decreases serum high-sensitivity C-reactive protein level in experimental atherogenesis of rabbits. Heart and Vessels 24(6): 446-453

Metformin inhibits nuclear factor-κB activation and inflammatory cytokines expression induced by high glucose via adenosine monophosphate-activated protein kinase activation in rat glomerular mesangial cells in vitro. Chinese Medical Journal 127(9): 1755-1760

Metformin inhibits pancreatic cancer cell and tumor growth and downregulates Sp transcription factors. Carcinogenesis 34(12): 2870-2879

Metformin inhibits proliferation and enhances chemosensitivity of intrahepatic cholangiocarcinoma cell lines. Oncology Reports 31(6): 2611-2618

Metformin inhibits proliferation and promotes apoptosis of HER2 positive breast cancer cells by downregulating HSP90. Journal of B.U.On. 18(1): 51-56

Metformin inhibits proliferation of human keratinocytes through a mechanism associated with activation of the MAPK signaling pathway. Experimental and Therapeutic Medicine 7(2): 389-392

Metformin inhibits skin tumor promotion in overweight and obese mice . Cancer Prevention Research 7(1): 54-64

Metformin inhibits the IL-6-induced epithelial-mesenchymal transition and lung adenocarcinoma growth and metastasis. Plos One 9(4): E95884-E95884

Metformin inhibits the development and metastasis of ovarian cancer. Oncology Reports 28(3): 903-908

Metformin inhibits the growth of human pancreatic cancer xenografts. Pancreas 42(5): 781-785

Metformin inhibits the growth of nasopharyngeal carcinoma cells and sensitizes the cells to radiation via inhibition of the DNA damage repair pathway. Oncology Reports 32(6): 2596-2604

Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth. Proceedings of the National Academy of Sciences of the United States of America 110(3): 972-977

Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression. Amino Acids 46(12): 2809-2822

Metformin inhibits the proliferation of A549/CDDP cells by activating p38 mitogen-activated protein kinase. Oncology Letters 8(3): 1269-1274

Metformin inhibits the proliferation of hypopharyngeal carcinoma Fadu cells and enhances the chemotherapeutic sensitivity of cells. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 49(4): 317-322

Metformin inhibits tumor cell migration via down-regulation of MMP9 in tamoxifen-resistant breast cancer cells. Anticancer Research 34(8): 4127-4134

Metformin inhibits vascular calcification in female rat aortic smooth muscle cells via the AMPK-eNOS-NO pathway. Endocrinology 154(10): 3680-3689

Metformin intake is associated with better survival in ovarian cancer: a case-control study. Cancer 119(3): 555-562

Metformin interacts with AMPK through binding to γ subunit. Molecular and Cellular Biochemistry 368(1-2): 69-76

Metformin interferes with bile acid homeostasis through AMPK-FXR crosstalk. Journal of Clinical Investigation 124(3): 1037-1051

Metformin intoxication requiring dialysis. Hemodialysis International. International Symposium on Home Hemodialysis 15 Suppl 1: S68-S71

Metformin is a potent inhibitor of endometrial cancer cell proliferation--implications for a novel treatment strategy. Gynecologic Oncology 116(1): 92-98

Metformin is a reasonable first-line treatment option for non-obese women with infertility related to anovulatory polycystic ovary syndrome--a meta-analysis of randomised trials. Australian & New Zealand Journal of Obstetrics & Gynaecology 51(2): 125-129

Metformin is a unique drug. Canadian Family Physician Medecin de Famille Canadien 55(6): 589; Author Reply 589-589; Author Reply 589

Metformin is associated with improved left ventricular diastolic function measured by tissue Doppler imaging in patients with diabetes. European Journal of Endocrinology 163(4): 593-599

Metformin is associated with improved survival in endometrial cancer. Gynecologic Oncology 132(2): 438-442

Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetes Research and Clinical Practice 106(1): 19-26

Metformin is associated with survival benefit in cancer patients with concurrent type 2 diabetes: a systematic review and meta-analysis. Oncologist 18(12): 1248-1255

Metformin is effective in achieving biochemical response in patients with nonalcoholic fatty liver disease (NAFLD) not responding to lifestyle interventions. Annals of Hepatology 6(4): 222-226

Metformin is not associated with improved biochemical free survival or cause-specific survival in men with prostate cancer treated with permanent interstitial brachytherapy. Journal of Contemporary BrachyTherapy 6(3): 254-261

Metformin is synthetically lethal with glucose withdrawal in cancer cells. Cell Cycle 11(15): 2779-2780

Metformin limits ceramide-induced senescence in C2C12 myoblasts. Mechanisms of Ageing and Development 134(11-12): 548-559

Metformin limits the adipocyte tumor-promoting effect on ovarian cancer. Oncotarget 5(13): 4746-4764

Metformin loaded non-ionic surfactant vesicles: optimization of formulation, effect of process variables and characterization. Daru 21(1): 7-7

Metformin lowers plasma triglycerides by promoting VLDL-triglyceride clearance by brown adipose tissue in mice. Diabetes 63(3): 880-891

Metformin lowers serum cobalamin without changing other markers of cobalamin status: a study on women with polycystic ovary syndrome. Nutrients 5(7): 2475-2482

Metformin lowers the threshold for stress-induced senescence: a role for the microRNA-200 family and miR-205. Cell Cycle 11(6): 1235-1246

Metformin maintains the weight loss and metabolic benefits following rimonabant treatment in obese women with polycystic ovary syndrome (PCOS). Clinical Endocrinology 70(1): 124-128

Metformin may aid weight loss in overweight teenage girls. Journal of Pediatrics 153(5): 725-726

Metformin may be associated with false-negative cancer detection in the gastrointestinal tract on PET/CT. Endocrine Practice 20(10): 1079-1083

Metformin may function as anti-cancer agent via targeting cancer stem cells: the potential biological significance of tumor-associated miRNAs in breast and pancreatic cancers. Annals of Translational Medicine 2(6): 59-59

Metformin may maintain weight loss in obese patients with dysglycaemia initially treated with rimonabant. Diabetic Medicine 28(1): 124-125

Metformin may produce antidepressant effects through improvement of cognitive function among depressed patients with diabetes mellitus. Clinical and Experimental Pharmacology & Physiology 41(9): 650-656

Metformin may reduce bladder cancer risk in Taiwanese patients with type 2 diabetes. Acta Diabetologica 51(2): 295-303

Metformin may reduce breast cancer risk in Taiwanese women with type 2 diabetes. Breast Cancer Research and Treatment 145(3): 785-790

Metformin mitigates apoptosis in ischemic myocardium. Journal of Surgical Research 192(1): 50-58

Metformin modulates IL-8, IL-1β, ICAM and IGFBP-1 expression in human endometrial stromal cells. Reproductive Biomedicine Online 22(4): 327-334

Metformin modulates PI3K and GLUT4 expression and Akt/PKB phosphorylation in human endometrial stromal cells after stimulation with androgen and insulin. European Journal of Obstetrics, Gynecology, and Reproductive Biology 175(): 157-162

Metformin modulates hyperglycaemia-induced endothelial senescence and apoptosis through SIRT1. British Journal of Pharmacology 171(2): 523-535

Metformin monitoring.. Canadian Family Physician Medecin de Famille Canadien 26: 638-639

Metformin nephrotoxicity insights: will they change clinical management?. Journal of Diabetes 6(2): 111-112

Metformin normalizes endothelial function by suppressing vasoconstrictor prostanoids in mesenteric arteries from OLETF rats, a model of type 2 diabetes. American Journal of Physiology. Heart and Circulatory Physiology 295(3): H1165-H1176

Metformin normalizes type 2 diabetes-induced decrease in cell proliferation and neuroblast differentiation in the rat dentate gyrus. Neurochemical Research 35(4): 645-650

Metformin opposes impaired AMPK and SIRT1 function and deleterious changes in core clock protein expression in white adipose tissue of genetically-obese db/db mice. Diabetes, Obesity & Metabolism 13(12): 1097-1104

Metformin overdose with a resultant serum pH of 6.59: survival without sequalae. Journal of Emergency Medicine 39(1): E77-E80

Metformin overdose-induced hypoglycemia in the absence of other antidiabetic drugs. Clinical Toxicology 51(5): 444-447

Metformin pathways: pharmacokinetics and pharmacodynamics. Pharmacogenetics and Genomics 22(11): 820-827

Metformin pharmacogenomics: biomarkers to mechanisms. Diabetes 63(8): 2609-2610

Metformin pharmacogenomics: current status and future directions. Diabetes 63(8): 2590-2599

Metformin plays a dual role in MIN6 pancreatic β cell function through AMPK-dependent autophagy. International Journal of Biological Sciences 10(3): 268-277

Metformin plus PIAF combination chemotherapy for hepatocellular carcinoma. Experimental Oncology 34(1): 17-24

Metformin plus a lifestyle intervention was more effective than either alone for antipsychotic-induced weight gain. Acp Journal Club 149(2): 5-5

Metformin plus low-dose glimeperide significantly improves Homeostasis Model Assessment for insulin resistance (HOMA(IR)) and beta-cell function (HOMA(beta-cell)) without hyperinsulinemia in patients with type 2 diabetes mellitus. American Journal of Therapeutics 14(2): 194-202

Metformin plus oral contraceptive may decrease plasma sCD40 ligand in women with PCOS patients. Gynecological Endocrinology 27(2): 91-95

Metformin plus pentoxifylline versus prescriptive diet in non-alcoholic steatohepatitis (NASH): a randomized controlled pilot trial. Gastroenterologie Clinique et Biologique 33(10-11): 984-986

Metformin plus sorafenib highly impacts temozolomide resistant glioblastoma stem-like cells. Journal of B.U.On. 19(2): 502-511

Metformin plus temozolomide-based chemotherapy as adjuvant treatment for WHO grade III and IV malignant gliomas. Journal of B.U.On. 16(2): 282-289

Metformin poisoning--clinical features, diagnostics and treatment--case presentations. Przeglad Lekarski 70(8): 661-665

Metformin poisoning: A complex presentation. Indian Journal of Anaesthesia 55(2): 190-192

Metformin potentiates the anticancer effects of cisplatin under normoxic conditions in vitro. Oncology Reports 33(2): 744-750

Metformin powder formulation compared to metformin tablets on glycemic control and on treatment satisfaction in subjects with type 2 diabetes mellitus. Journal of Clinical Pharmacology 55(4): 409-414

Metformin preconditioning protects Daphnia pulex from lethal hypoxic insult involving AMPK, HIF and mTOR signaling. Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology 163(1): 51-58

Metformin prevents LYRM1-induced insulin resistance in 3T3-L1 adipocytes via a mitochondrial-dependent mechanism. Experimental Biology and Medicine 239(12): 1567-1574

Metformin prevents and reverses inflammation in a non-diabetic mouse model of nonalcoholic steatohepatitis. Plos One 7(9): E43056-E43056

Metformin prevents endoplasmic reticulum stress-induced apoptosis through AMPK-PI3K-c-Jun NH2 pathway. Biochemical and Biophysical Research Communications 417(1): 147-152

Metformin prevents hepatic steatosis by regulating the expression of adipose differentiation-related protein. International Journal of Molecular Medicine 33(1): 51-58

Metformin prevents liver tumorigenesis by inhibiting pathways driving hepatic lipogenesis. Cancer Prevention Research 5(4): 544-552

Metformin prevents liver tumorigenesis induced by high-fat diet in C57Bl/6 mice. American Journal of Physiology. Endocrinology and Metabolism 305(8): E987-E998

Metformin prevents myocardial reperfusion injury by activating the adenosine receptor. Journal of Cardiovascular Pharmacology 53(5): 373-378

Metformin prevents non-alcoholic fatty liver disease in rats: role of phospholipase A2/lysophosphatidylcholine lipoapoptosis pathway in hepatocytes. Zhonghua Er Ke Za Zhi 49(2): 139-145

Metformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase. Circulation 119(19): 2568-2577

Metformin prevents the development of oral squamous cell carcinomas from carcinogen-induced premalignant lesions. Cancer Prevention Research 5(4): 562-573

Metformin prevents tobacco carcinogen--induced lung tumorigenesis. Cancer Prevention Research 3(9): 1066-1076

Metformin primarily decreases plasma glucose not by gluconeogenesis suppression but by activating glucose utilization in a non-obese type 2 diabetes Goto-Kakizaki rats. European Journal of Pharmacology 623(1-3): 141-147

Metformin promotes focal angiogenesis and neurogenesis in mice following middle cerebral artery occlusion. Neuroscience Letters 579: 46-51

Metformin promotes induction of lipoprotein lipase in skeletal muscle through activation of adenosine monophosphate-activated protein kinase. Metabolism: Clinical and Experimental 58(10): 1408-1414

Metformin promotes irisin release from murine skeletal muscle independently of AMP-activated protein kinase activation. Acta Physiologica 213(3): 711-721

Metformin promotes lifespan through mitohormesis via the peroxiredoxin PRDX-2. Proceedings of the National Academy of Sciences of the United States of America 111(24): E2501-9

Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells. Journal of Steroid Biochemistry and Molecular Biology 126(3-5): 113-120

Metformin protects against gentamicin-induced hair cell death in vitro but not ototoxicity in vivo. Neuroscience Letters 583: 65-69

Metformin protects against hyperglycemia-induced cardiomyocytes injury by inhibiting the expressions of receptor for advanced glycation end products and high mobility group box 1 protein. Molecular Biology Reports 41(3): 1335-1340

Metformin protects against seizures, learning and memory impairments and oxidative damage induced by pentylenetetrazole-induced kindling in mice. Biochemical and Biophysical Research Communications 448(4): 414-417

Metformin protects against systolic overload-induced heart failure independent of AMP-activated protein kinase α2. Hypertension 63(4): 723-728

Metformin protects cardiomyocyte from doxorubicin induced cytotoxicity through an AMP-activated protein kinase dependent signaling pathway: an in vitro study. Plos One 9(8): E104888-E104888

Metformin protects endothelial function in diet-induced obese mice by inhibition of endoplasmic reticulum stress through 5' adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor δ pathway. Arteriosclerosis, Thrombosis, and Vascular Biology 34(4): 830-836

Metformin protects rat hepatocytes against bile acid-induced apoptosis. Plos One 8(8): E71773-E71773

Metformin protects the brain against the oxidative imbalance promoted by type 2 diabetes. Medicinal Chemistry ) 4(4): 358-364

Metformin protects the myocardium against isoproterenol-induced injury in rats through alleviating endoplasmic reticulum stress. Die Pharmazie 69(1): 64-69

Metformin provides weight reduction for hospitalized patients receiving polypharmacy. Journal of Clinical Psychopharmacology 30(3): 345-346

Metformin raises hydrogen sulfide tissue concentrations in various mouse organs. Pharmacological Reports 65(3): 737-742

Metformin reduces NAD(P)H oxidase activity in mouse cultured podocytes through purinergic dependent mechanism by increasing extracellular ATP concentration. Acta Biochimica Polonica 60(4): 607-612

Metformin reduces TGF-β1-induced extracellular matrix production in nasal polyp-derived fibroblasts. Otolaryngology--Head and Neck Surgery 150(1): 148-153

Metformin reduces airway inflammation and remodeling via activation of AMP-activated protein kinase. Biochemical Pharmacology 84(12): 1660-1670

Metformin reduces arterial stiffness and improves endothelial function in young women with polycystic ovary syndrome: a randomized, placebo-controlled, crossover trial. Journal of Clinical Endocrinology and Metabolism 95(2): 722-730

Metformin reduces asymmetric dimethylarginine and prevents hypertension in spontaneously hypertensive rats. Translational Research 164(6): 452-459

Metformin reduces body weight gain and improves glucose intolerance in high-fat diet-fed C57BL/6J mice. Biological & Pharmaceutical Bulletin 33(6): 963-970

Metformin reduces circulating malondialdehyde-modified low-density lipoprotein in type 2 diabetes mellitus. Clinical and Investigative Medicine. Medecine Clinique et Experimentale 37(4): E243-E251

Metformin reduces cisplatin-mediated apoptotic death of cancer cells through AMPK-independent activation of Akt. European Journal of Pharmacology 651(1-3): 41-50

Metformin reduces endogenous reactive oxygen species and associated DNA damage. Cancer Prevention Research 5(4): 536-543

Metformin reduces hepatic expression of SIRT3, the mitochondrial deacetylase controlling energy metabolism. Plos One 7(11): E49863-E49863

Metformin reduces intracellular reactive oxygen species levels by upregulating expression of the antioxidant thioredoxin via the AMPK-FOXO3 pathway. Biochemical and Biophysical Research Communications 396(2): 199-205

Metformin reduces lipid accumulation in macrophages by inhibiting FOXO1-mediated transcription of fatty acid-binding protein 4. Biochemical and Biophysical Research Communications 393(1): 89-94

Metformin reduces the expression of corticotropin-releasing hormone and urocortin in the endometrium of healthy women. Fertility and Sterility 100(5): 1405-1409

Metformin reduces the stimulatory effect of obesity on in vivo Walker-256 tumor development and increases the area of tumor necrosis. Life Sciences 88(19-20): 846-852

Metformin reduces thyroid cancer risk in Taiwanese patients with type 2 diabetes. Plos One 9(10): E109852-E109852

Metformin reduces vascular endothelial dysfunction caused by an acute glucose load in patients with hypertension. Blood Pressure 22(2): 106-113

Metformin regresses endometriotic implants in rats by improving implant levels of superoxide dismutase, vascular endothelial growth factor, tissue inhibitor of metalloproteinase-2, and matrix metalloproteinase-9. American Journal of Obstetrics and Gynecology 202(4): 368.E1-8

Metformin regulates breast cancer stem cell ontogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status. Cell Cycle 9(18): 3807-3814

Metformin regulates glucose transporter 4 (GLUT4) translocation through AMP-activated protein kinase (AMPK)-mediated Cbl/CAP signaling in 3T3-L1 preadipocyte cells. Journal of Biological Chemistry 287(53): 44121-9

Metformin regulates osteoblast and adipocyte differentiation of rat mesenchymal stem cells. Journal of Pharmacy and Pharmacology 60(12): 1695-1700

Metformin regulates palmitate-induced apoptosis and ER stress response in HepG2 liver cells. Immunopharmacology and Immunotoxicology 32(2): 251-257

Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-α in mice. Diabetologia 54(2): 339-349

Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion current. Oncotarget 5(22): 11252-11268

Metformin represses drug-induced expression of CYP2B6 by modulating the constitutive androstane receptor signaling. Molecular Pharmacology 85(2): 249-260

Metformin represses self-renewal of the human breast carcinoma stem cells via inhibition of estrogen receptor-mediated OCT4 expression. Plos One 6(11): E28068-E28068

Metformin rescues cell surface major histocompatibility complex class I (MHC-I) deficiency caused by oncogenic transformation. Cell Cycle 11(5): 865-870

Metformin rescues the MG63 osteoblasts against the effect of high glucose on proliferation. Journal of Diabetes Research 2014: 453940-453940

Metformin rescues the myocardium from doxorubicin-induced energy starvation and mitochondrial damage in rats. Oxidative Medicine and Cellular Longevity 2012: 434195-434195

Metformin resistance alleles in polycystic ovary syndrome: pattern and association with glucose metabolism. Pharmacogenomics 15(3): 305-317

Metformin restores endothelial function in aorta of diabetic rats. British Journal of Pharmacology 163(2): 424-437

Metformin restores impaired HDL-mediated cholesterol efflux due to glycation. Atherosclerosis 206(2): 434-438

Metformin restores the correlation between serum-oxidized LDL and leptin levels in type 2 diabetic patients. Redox Report 16(5): 193-200

Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism. Cell 153(1): 228-239

Metformin reverses hexokinase and 6-phosphofructo-1-kinase inhibition in skeletal muscle, liver and adipose tissues from streptozotocin-induced diabetic mouse. Archives of Biochemistry and Biophysics 496(1): 53-60

Metformin reverses multidrug resistance and epithelial-mesenchymal transition (EMT) via activating AMP-activated protein kinase (AMPK) in human breast cancer cells. Molecular and Cellular Biochemistry 386(1-2): 63-71

Metformin reverses multidrug resistance in human hepatocellular carcinoma Bel‑7402/5‑fluorouracil cells. Molecular Medicine Reports 10(6): 2891-2897

Metformin reverses progestin resistance in endometrial cancer cells by downregulating GloI expression. International Journal of Gynecological Cancer 21(2): 213-221

Metformin reverses the deleterious effects of high glucose on osteoblast function. Journal of Diabetes and Its Complications 24(5): 334-344

Metformin role in the treatment of type 2 diabetes in 2008. Revue Medicale Suisse 4(160): 1392-4, 1396-7

Metformin safety in the management of gestational diabetes. Endocrine Practice 20(10): 1022-1031

Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of Akt. Cell Cycle 12(1): 145-156

Metformin selectively attenuates mitochondrial H2O2 emission without affecting respiratory capacity in skeletal muscle of obese rats. Free Radical Biology & Medicine 49(6): 1082-1087

Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission. Cancer Research 69(19): 7507-7511

Metformin selectively targets tumor-initiating cells in ErbB2-overexpressing breast cancer models. Cancer Prevention Research 7(2): 199-210

Metformin sensitizes EGFR-TKI-resistant human lung cancer cells in vitro and in vivo through inhibition of IL-6 signaling and EMT reversal. Clinical Cancer Research 20(10): 2714-2726

Metformin sensitizes anticancer effect of dasatinib in head and neck squamous cell carcinoma cells through AMPK-dependent ER stress. Oncotarget 5(1): 298-308

Metformin sensitizes chemotherapy by targeting cancer stem cells and the mTOR pathway in esophageal cancer. International Journal of Oncology 45(2): 567-574

Metformin sensitizes human bladder cancer cells to TRAIL-induced apoptosis through mTOR/S6K1-mediated downregulation of c-FLIP. Anti-Cancer Drugs 25(8): 887-897

Metformin sensitizes insulin signaling through AMPK-mediated PTEN down-regulation in preadipocyte 3T3-L1 cells. Journal of Cellular Biochemistry 112(5): 1259-1267

Metformin sensitizes prostate cancer cells to radiation through EGFR/p-DNA-PKCS in vitro and in vivo. Radiation Research 181(6): 641-649

Metformin should be considered in the treatment of gestational diabetes: a prospective randomised study. Bjog 118(7): 880-885

Metformin should not be used by patients with reduced renal function. Tidsskrift for den Norske Laegeforening 128(8): 936-937

Metformin significantly reduces incident prostate cancer risk in Taiwanese men with type 2 diabetes mellitus. European Journal of Cancer 50(16): 2831-2837

Metformin sinusoidal efflux from the liver is consistent with negligible biliary excretion and absence of enterohepatic cycling. Drug Metabolism and Disposition: the Biological Fate of Chemicals 41(11): 1967-1971

Metformin slows down aging and extends life span of female SHR mice. Cell Cycle 7(17): 2769-2773

Metformin stimulates ischemia-induced revascularization through an eNOS dependent pathway in the ischemic hindlimb mice model. Journal of Vascular Surgery 61(2): 489-496

Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats. Journal of Cellular Biochemistry 112(10): 2902-2909

Metformin stinks, literally. Annals of Internal Medicine 152(4): 267-268

Metformin superior to low‑fat diet for the treatment of patients with nonalcoholic fatty liver disease and/or steatohepatitis. Polskie Archiwum Medycyny Wewnetrznej 122 Suppl 1: 68-71

Metformin supplementation and life span in Fischer-344 rats. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 65(5): 468-474

Metformin supports the antidiabetic effect of a sodium glucose cotransporter 2 inhibitor by suppressing endogenous glucose production in diabetic mice. Diabetes 64(1): 284-290

Metformin suppresses CYP1A1 and CYP1B1 expression in breast cancer cells by down-regulating aryl hydrocarbon receptor expression. Toxicology and Applied Pharmacology 280(1): 138-148

Metformin suppresses azoxymethane-induced colorectal aberrant crypt foci by activating AMP-activated protein kinase. Molecular Carcinogenesis 49(7): 662-671

Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial. Cancer Prevention Research 3(9): 1077-1083

Metformin suppresses expression of the selenoprotein P gene via an AMP-activated kinase (AMPK)/FoxO3a pathway in H4IIEC3 hepatocytes. Journal of Biological Chemistry 289(1): 335-345

Metformin suppresses glucose-6-phosphatase expression by a complex I inhibition and AMPK activation-independent mechanism. Biochemical and Biophysical Research Communications 388(2): 311-316

Metformin suppresses growth of human head and neck squamous cell carcinoma via global inhibition of protein translation. Cell Cycle 11(7): 1374-1382

Metformin suppresses hepatic gluconeogenesis and lowers fasting blood glucose levels through reactive nitrogen species in mice. Diabetologia 53(7): 1472-1481

Metformin suppresses hepatic gluconeogenesis through induction of SIRT1 and GCN5. Journal of Endocrinology 205(1): 97-106

Metformin suppresses hepatocellular carcinoma cell growth through induction of cell cycle G1/G0 phase arrest and p21CIP and p27KIP expression and downregulation of cyclin D1 in vitro and in vivo. Oncology Reports 30(5): 2449-2457

Metformin suppresses high glucose-induced poly(adenosine diphosphate-ribose) polymerase overactivation in aortic endothelial cells. Metabolism: Clinical and Experimental 58(4): 525-533

Metformin suppresses interleukin (IL)-1beta-induced IL-8 production, aromatase activation, and proliferation of endometriotic stromal cells. Journal of Clinical Endocrinology and Metabolism 92(8): 3213-3218

Metformin suppresses intestinal polyp growth in ApcMin/+ mice. Cancer Science 99(11): 2136-2141

Metformin suppresses lipid accumulation in skeletal muscle by promoting fatty acid oxidation. Clinical Laboratory 60(6): 887-896

Metformin suppresses lipopolysaccharide (LPS)-induced inflammatory response in murine macrophages via activating transcription factor-3 (ATF-3) induction. Journal of Biological Chemistry 289(33): 23246-23255

Metformin suppresses ovarian cancer growth and metastasis with enhancement of cisplatin cytotoxicity in vivo. Neoplasia 13(5): 483-491

Metformin suppresses pregnane X receptor (PXR)-regulated transactivation of CYP3A4 gene. Biochemical Pharmacology 82(11): 1771-1780

Metformin suppresses sonic hedgehog expression in pancreatic cancer cells. Anticancer Research 34(4): 1765-1769

Metformin synergistically enhances antiproliferative effects of cisplatin and etoposide in NCI-H460 human lung cancer cells. Jornal Brasileiro de Pneumologia 39(6): 644-649

Metformin synergistically enhances antitumor activity of histone deacetylase inhibitor trichostatin a against osteosarcoma cell line. Dna and Cell Biology 32(4): 156-164

Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancers. Cell Cycle 11(2): 367-376

Metformin targets c-MYC oncogene to prevent prostate cancer. Carcinogenesis 34(12): 2823-2832

Metformin targets ovarian cancer stem cells in vitro and in vivo. Gynecologic Oncology 127(2): 390-397

Metformin targets the metabolic achilles heel of human pancreatic cancer stem cells. Plos One 8(10): E76518-E76518

Metformin therapy and clinical uses. Diabetes & Vascular Disease Research 5(3): 157-167

Metformin therapy and its anti-neoplastic role in systemic malignancies besides hepatocellular carcinomas. Scandinavian Journal of Gastroenterology 48(5): 636-637

Metformin therapy and kidney disease: a review of guidelines and proposals for metformin withdrawal around the world. Pharmacoepidemiology and Drug Safety 22(10): 1027-1035

Metformin therapy and outcomes in patients with advanced systolic heart failure and diabetes. Journal of Cardiac Failure 16(3): 200-206

Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review. Plos One 8(8): E71583-E71583

Metformin therapy decreases hyperandrogenism and ovarian volume in women with polycystic ovary syndrome . Iranian Journal of Medical Sciences 36(2): 90-95

Metformin therapy during pregnancy: good for the goose and good for the gosling too?. Diabetes Care 34(10): 2329-2330

Metformin therapy in girls with polycystic ovary syndrome: a self-controlled clinical trial. Archives of Iranian Medicine 10(2): 176-181

Metformin therapy in patients with type 2 diabetes complicated by heart failure. American Heart Journal 154(6): E45-E45

Metformin therapy in polycystic ovary syndrome. Ginekologia Polska 79(1): 8-11

Metformin therapy to reduce weight gain and visceral adiposity in children and adolescents with neurogenic or myogenic motor deficit. Pediatric Diabetes 11(1): 61-69

Metformin to prevent prostate cancer: a call to unite. European Urology 66(6): 1021-1022

Metformin toxicity. European Journal of Emergency Medicine 16(6): 348-349

Metformin toxicity: a report of 204 cases from Iran. Current Drug Safety 8(4): 278-281

Metformin treatment alters memory function in a mouse model of Alzheimer's disease. Journal of Alzheimer's Disease 44(1): 43-48

Metformin treatment and evolution of endometrial cancer. Climacteric 17(2): 207-209

Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome. Cochrane Database of Systematic Reviews (): Cd006105-Cd006105

Metformin treatment causes persisting lactic acidosis after cardiac arrest. Ugeskrift for Laeger 172(49): 3418-3419

Metformin treatment exerts antiinvasive and antimetastatic effects in human endometrial carcinoma cells. Journal of Clinical Endocrinology and Metabolism 96(3): 808-816

Metformin treatment for Type 2 diabetes in pregnancy?. Best Practice & Research. Clinical Endocrinology & Metabolism 24(4): 625-634

Metformin treatment for adolescent obesity has limited long-term benefits. Journal of Pediatrics 157(1): 172-172

Metformin treatment for small benign thyroid nodules in patients with insulin resistance. Metabolic Syndrome and Related Disorders 9(1): 69-75

Metformin treatment has no beneficial effect in a dose-response survival study in the SOD1(G93A) mouse model of ALS and is harmful in female mice. Plos One 6(9): E24189-E24189

Metformin treatment improves erectile function in an angiotensin II model of erectile dysfunction. Journal of Sexual Medicine 10(9): 2154-2164

Metformin treatment improves weight and dyslipidemia in children with metabolic syndrome. Journal of Pediatric Endocrinology & Metabolism 28(5-6): 649-655

Metformin treatment in diabetes and heart failure: when academic equipoise meets clinical reality. Trials 10(): 12-12

Metformin treatment in different phenotypes of polycystic ovary syndrome. Archives of Gynecology and Obstetrics 288(5): 1131-1136

Metformin treatment in hyperglycemic critically ill patients: another challenge on the control of adverse outcomes. Iranian Journal of Pharmaceutical Research 10(4): 913-919

Metformin treatment is associated with a low risk of mortality in diabetic patients with heart failure: a retrospective nationwide cohort study. Diabetologia 53(12): 2546-2553

Metformin treatment may be associated with decreased levels of NT-proBNP in patients with type 2 diabetes. Advances in Medical Sciences 58(2): 362-368

Metformin treatment may increase omentin-1 levels in women with polycystic ovary syndrome. Diabetes 59(12): 3023-3031

Metformin treatment of diabetes mellitus increases the risk for pancreatitis in patients bearing the CFTR-mutation S573C. Cellular Physiology and Biochemistry 25(4-5): 389-396

Metformin treatment to reduce central adiposity after prenatal growth restraint: a placebo-controlled pilot study in prepubertal children. Pediatric Diabetes 16(7): 538-545

Metformin treatment with or without life style changes in patients with polycystic ovary syndrome. Orvosi Hetilap 152(16): 628-632

Metformin usage in type 2 diabetes mellitus: are safety guidelines adhered to?. Internal Medicine Journal 44(3): 266-272

Metformin usages in women with heart failure. American Journal of Obstetrics and Gynecology 201(1): E18; Author Reply E18-9

Metformin use among type 2 diabetics and risk of pancreatic cancer in a clinic-based case-control study. International Journal of Cancer 136(6): E646-E653

Metformin use and all-cause and prostate cancer-specific mortality among men with diabetes. Journal of Clinical Oncology 31(25): 3069-3075

Metformin use and endometrial cancer survival. Gynecologic Oncology 132(1): 236-240

Metformin use and improved response to therapy in esophageal adenocarcinoma. Acta Oncologica 52(5): 1002-1009

Metformin use and improved response to therapy in rectal cancer. Cancer Medicine 2(1): 99-107

Metformin use and mortality among patients with diabetes and atherothrombosis. Archives of Internal Medicine 170(21): 1892-1899

Metformin use and mortality in ambulatory patients with diabetes and heart failure. Circulation. Heart Failure 4(1): 53-58

Metformin use and prostate cancer in Caucasian men: results from a population-based case-control study. Cancer Causes & Control 20(9): 1617-1622

Metformin use and prostate cancer risk. European Urology 66(6): 1012-1020

Metformin use decreases the anticoagulant effect of phenprocoumon. Journal of Thrombosis and Haemostasis 12(6): 887-890

Metformin use in adolescents. American Family Physician 87(8): Od4-Od4

Metformin use in an obese diabetic patient from weeks 1 to 21 of pregnancy. Journal of Medicine 34(1-6): 163-168

Metformin use in children with obesity and normal glucose tolerance--effects on cardiovascular markers and intrahepatic fat. Journal of Pediatric Endocrinology & Metabolism 25(1-2): 33-40

Metformin use in chronic kidney disease: new evidence to guide dosing. Qjm 106(11): 1059-1061

Metformin use in decompensated heart failure. Cardiology in Review 16(5): 269-272

Metformin use in gestational diabetes mellitus. Diabetes Research and Clinical Practice 105(1): E1-E2

Metformin use in patients with diabetes mellitus and heart failure: friend or foe?. Journal of Cardiac Failure 16(3): 207-210

Metformin use in polycystic ovary syndrome: metabolic benefits and diabetes prevention. American Journal of Medicine 121(8): E9; Author Reply E11-E9; Author Reply E11

Metformin use in renal dysfunction: is a serum creatinine threshold appropriate?. American Journal of Health-System Pharmacy 66(22): 2017-2023

Metformin use in women with polycystic ovary syndrome. Annals of Translational Medicine 2(6): 56-56

Metformin use is associated with better survival of diabetic patients with pancreatic cancer. Clinical Cancer Research 18(10): 2905-2912

Metformin versus acarbose therapy in patients with polycystic ovary syndrome (PCOS): a prospective randomised double-blind study. Gynecological Endocrinology 26(9): 690-697

Metformin versus chromium picolinate in clomiphene citrate-resistant patients with PCOs: A double-blind randomized clinical trial. Iranian Journal of Reproductive Medicine 11(8): 611-618

Metformin versus laparoscopic ovarian drilling in clomiphene- and insulin-resistant women with polycystic ovary syndrome. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 108(2): 143-147

Metformin versus lifestyle changes in treating women with polycystic ovary syndrome. Gynecological Endocrinology 28(3): 182-185

Metformin versus metformin plus rosiglitazone in women with polycystic ovary syndrome. Chinese Medical Journal 124(5): 714-718

Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study. Journal of Clinical Endocrinology and Metabolism 95(12): E448-E455

Metformin vs insulin in the management of gestational diabetes: a meta-analysis. Plos One 8(5): E64585-E64585

Metformin vs insulin in the management of gestational diabetes: a systematic review and meta-analysis. Diabetes Research and Clinical Practice 104(3): 353-357

Metformin vs thiazolidinediones for treatment of clinical, hormonal and metabolic characteristics of polycystic ovary syndrome: a meta-analysis. Clinical Endocrinology 74(3): 332-339

Metformin's effect on exercise and postexercise substrate oxidation. International Journal of Sport Nutrition and Exercise Metabolism 20(1): 63-71

Metformin's performance in in vitro and in vivo genetic toxicology studies. Experimental Biology and Medicine 238(7): 803-810

Metformin's potential in oncology. Clinical Advances in Hematology & Oncology 11(9): 594-595

Metformin, B(12), and enhanced breast cancer response to chemotherapy. Journal of Clinical Oncology 28(2): E19; Author Reply E20-E19; Author Reply E20

Metformin, B12 and homocysteine levels: the plausible cause or effect?. Journal of the Formosan Medical Association 107(6): 505-6; Author Reply 507

Metformin, a diabetes drug, eliminates tumor-initiating hepatocellular carcinoma cells. Plos One 8(7): E70010-E70010

Metformin, aging and cancer. Aging 5(5): 330-331

Metformin, an antidiabetic agent, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitro. Journal of Pharmacology and Experimental Therapeutics 334(1): 206-213

Metformin, an antidiabetic molecule with anti-cancer properties. Revue Medicale de Liege 68(9): 444-449

Metformin, but not glimepiride, improves carotid artery diameter and blood flow in patients with type 2 diabetes mellitus. Clinics 67(7): 711-717

Metformin, but not pioglitazone, decreases postchallenge plasma ghrelin levels in type 2 diabetic patients: a possible role in weight stability?. Diabetes, Obesity & Metabolism 10(11): 1039-1046

Metformin, but not rosiglitazone, attenuates the increasing plasma levels of a new cardiovascular marker, fibulin-1, in patients with type 2 diabetes. Diabetes Care 37(3): 760-766

Metformin, cancer and glucose metabolism. Endocrine-Related Cancer 21(6): R461-R471

Metformin, cancer, alphabet soup, and the role of epidemiology in etiologic research. Diabetes Care 32(9): 1748-1750

Metformin, diet and breast cancer: an avenue for chemoprevention. Cell Cycle 8(16): 2661-2661

Metformin, estrogen replacement therapy and gonadotropin inhibition fail to improve insulin sensitivity in a girl with aromatase deficiency. Hormone Research 72(6): 370-376

Metformin, fifty years since the arrival of this molecule!. Journees Annuelles de Diabetologie de L'hotel-Dieu: 1-3

Metformin, hepatitis C, and insulin resistance: sufficient evidence?. Hepatology 50(6): 2054-5; Author Reply 2055

Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1. Cancer Research 71(13): 4366-4372

Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner. Cell Metabolism 11(5): 390-401

Metformin, insulin, breast cancer and more... Future Oncology 5(3): 309-312

Metformin, metabolic stress, and mitochondria. Focus on "A novel inverse relationship between metformin-triggered AMPK-SIRT1 signaling and p53 protein abundance in high glucose-exposed HepG2 cells". American Journal of Physiology. Cell Physiology 303(1): C1-C3

Metformin, naltrexone, or the combination of prednisolone and antiandrogenic oral contraceptives as first-line therapy in hyperinsulinemic women with polycystic ovary syndrome. Fertility and Sterility 94(6): 2385-2388

Metformin, oral contraceptives or both to manage oligo-amenorrhea in adolescents with polycystic ovary syndrome? A clinical review. Gynecological Endocrinology 30(5): 335-340

Metformin, renal function and lactate: the MetClear Study. Nederlands Tijdschrift Voor Geneeskunde 158(5): A6266-A6266

Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: a nested case-control analysis. Diabetes Care 31(11): 2086-2091

Metformin--a convenient alternative to insulin for Indian women with diabetes in pregnancy. Indian Journal of Medical Sciences 63(11): 491-497

Metformin--an adjunct antineoplastic therapy--divergently modulates tumor metabolism and proliferation, interfering with early response prediction by 18F-FDG PET imaging. Journal of Nuclear Medicine 54(2): 252-258

Metformin--an inhibitor of early stages of protein glycation. Folia Medica Cracoviensia 50(3-4): 21-33

Metformin--new treatment strategies for gynecologic neoplasms. Przeglad Lekarski 70(2): 81-84

Metformin--the gold standard in type 2 diabetes: what does the evidence tell us?. Diabetes, Obesity & Metabolism 11 Suppl 2: 3-8

Metformin-Induced Intense Bowel Uptake Observed on Restaging FDG PET/CT Study in a Patient with Gastric Lymphoma. Molecular Imaging and Radionuclide Therapy 20(3): 114-116

Metformin-associated acute kidney injury and lactic acidosis. International Journal of Nephrology 2011: 749653-749653

Metformin-associated hepatotoxicity. Medicina Intensiva 34(7): 483-487

Metformin-associated lactic acidosis. Emergency Nurse 22(5): 20-25

Metformin-associated lactic acidosis (MALA): case files of the Einstein Medical Center medical toxicology fellowship. Journal of Medical Toxicology 9(1): 61-66

Metformin-associated lactic acidosis (MALA): case report. Acta Clinica Belgica 66(5): 390-392

Metformin-associated lactic acidosis (MALA): clinical profile and outcomes in patients admitted to the intensive care unit. Critical Care and Resuscitation 12(3): 191-195

Metformin-associated lactic acidosis and acute renal failure secondary to cardiac catheterism. Nefrologia 27(3): 385-386

Metformin-associated lactic acidosis can be treated with continuous renal replacement therapy. Ugeskrift for Laeger 174(23): 1602-1603

Metformin-associated lactic acidosis following contrast media-induced nephrotoxicity. European Journal of Anaesthesiology 25(2): 166-167

Metformin-associated lactic acidosis in Chinese patients with type II diabetes. Pharmacology 88(5-6): 260-265

Metformin-associated lactic acidosis in a pregnant patient. Gynecologic and Obstetric Investigation 66(2): 138-141

Metformin-associated lactic acidosis in an intensive care unit. Critical Care 12(6): R149-R149

Metformin-associated lactic acidosis in an older adult after colonoscopy: an uncommon trigger for a rare complication. Journal of the American Geriatrics Society 61(12): 2257-2258

Metformin-associated lactic acidosis in patients with renal impairment solely due to drug accumulation?. Diabetes, Obesity & Metabolism 10(1): 91-93

Metformin-associated lactic acidosis in the Intensive Care Unit. Revista Espanola de Anestesiologia Y Reanimacion 61(8): 466-467

Metformin-associated lactic acidosis masquerading as ischemic bowel. American Journal of Medicine 125(5): E9-E9

Metformin-associated lactic acidosis precipitated by diarrhea. American Journal of Therapeutics 14(4): 403-405

Metformin-associated lactic acidosis presenting as an ischemic gut in a patient who then survived a cardiac arrest: a case report. Journal of Medical Case Reports 8(): 159-159

Metformin-associated lactic acidosis requiring hospitalization. A national 10 year survey and a systematic literature review. European Review for Medical and Pharmacological Sciences 17 Suppl 1(): 45-49

Metformin-associated lactic acidosis treated with prolonged hemodialysis. American Journal of Emergency Medicine 29(5): 575.E3-5

Metformin-associated lactic acidosis: a prognostic and therapeutic study. Critical Care Medicine 37(7): 2191-2196

Metformin-associated lactic acidosis: incidence, diagnosis, prognostic factors and treatment. Revista Espanola de Anestesiologia Y Reanimacion 59(5): 276-279

Metformin-associated lactic acidosis: is it really just an association?. American Journal of Emergency Medicine 29(3): 349-350

Metformin-based treatment for obesity-related hypertension: a randomized, double-blind, placebo-controlled trial. Journal of Hypertension 30(7): 1430-1439

Metformin-clomiphene citrate vs. clomiphene citrate alone: Polycystic ovarian syndrome. Journal of Human Reproductive Sciences 6(1): 15-18

Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort. Parkinsonism & Related Disorders 18(6): 753-758

Metformin-inclusive therapy reduces the risk of stroke in patients with diabetes: a 4-year follow-up study. Journal of Stroke and Cerebrovascular Diseases 23(2): E99-105

Metformin-induced acute lactic acidosis. Farmacia Hospitalaria 31(1): 71-72

Metformin-induced cholangiohepatitis. Bmj Case Reports 2009: -

Metformin-induced encephalopathy without lactic acidosis in a patient with contraindication for metformin. Hemodialysis International. International Symposium on Home Hemodialysis 13(2): 172-175

Metformin-induced hemolytic anemia. Medical Principles and Practice 23(2): 183-185

Metformin-induced hepatotoxicity. Diabetes Care 35(3): E21-E21

Metformin-induced inhibition of the mitochondrial respiratory chain increases FGF21 expression via ATF4 activation. Biochemical and Biophysical Research Communications 440(1): 76-81

Metformin-induced killing of triple-negative breast cancer cells is mediated by reduction in fatty acid synthase via miRNA-193b. Hormones & Cancer 5(6): 374-389

Metformin-induced lactic acidosis and acute pancreatitis precipitated by diuretic, celecoxib, and candesartan-associated acute kidney dysfunction. Clinical Toxicology 46(2): 164-166

Metformin-induced lactic acidosis associated with multiorganic failure. Medical Archives 67(5): 381-382

Metformin-induced lactic acidosis due to acute renal failure. Anales del Sistema Sanitario de Navarra 34(1): 115-118

Metformin-induced lactic acidosis in a type 2 diabetic patient with acute renal failure. La Clinica Terapeutica 159(2): 87-89

Metformin-induced lactic acidosis: a case series. Journal of Medical Case Reports 1(): 126-126

Metformin-induced lactic acidosis: no one left behind. Critical Care 15(1): 107-107

Metformin-induced lactic acidosis: usefulness of measuring levels and therapy with high-flux haemodialysis. Nefrologia 31(5): 610-611

Metformin-induced leukocytoclastic vasculitis: a case report. American Journal of Clinical Dermatology 13(1): 61-63

Metformin-induced metabolic reprogramming of chemoresistant ALDHbright breast cancer cells. Oncotarget 5(12): 4129-4143

Metformin-induced mixed hepatocellular and cholestatic hepatic injury: case report and literature review. International Journal of General Medicine 6(): 703-706

Metformin-induced paroxysmal dystonia. Neurosciences 13(2): 194-195

Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts. Oncotarget 3(4): 395-398

Metformin-induced pseudoporphyria. Journal of Drugs in Dermatology 11(11): 1272-1272

Metformin-induced regulation of the intestinal D-glucose transporters. Journal of Physiology and Pharmacology 61(3): 301-307

Metformin-induced thyrotropin suppression is not associated with cardiac effects. Hormones 13(2): 252-258

Metformin-induced vitamin B12 deficiency presenting as a peripheral neuropathy. Southern Medical Journal 103(3): 265-267

Metformin-letrozole in comparison with Metformin-clomiphene citrate in clomiphene-resistance PCOS patients undergoing IUI. Iranian Journal of Reproductive Medicine 9(1): 31-36

Metformin-loaded BSA nanoparticles in cancer therapy: a new perspective for an old antidiabetic drug. Cell Biochemistry and Biophysics 71(2): 627-636

Metformin-mediated Bambi expression in hepatic stellate cells induces prosurvival Wnt/β-catenin signaling. Cancer Prevention Research 5(4): 553-561

Metformin-mediated downregulation of p38 mitogen-activated protein kinase-dependent excision repair cross-complementing 1 decreases DNA repair capacity and sensitizes human lung cancer cells to paclitaxel. Biochemical Pharmacology 85(4): 583-594

Metformin-related lactic acidosis in an 85-year-old woman. Nederlands Tijdschrift Voor Geneeskunde 151(17): 977-980

Metformin-related lactic acidosis in patients with acute kidney injury. International Urology and Nephrology 43(4): 1243-1248

Metformin-responsive classic salt-losing congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a case report. Endocrine Practice 14(7): 889-891

Metformin-stimulated AMPK-α1 promotes microvascular repair in acute lung injury. American Journal of Physiology. Lung Cellular and Molecular Physiology 305(11): L844-L855

Metformin. Contraindications in heart failure reconsidered. Medizinische Monatsschrift für Pharmazeuten 31(4): 148-149

Metformin/Repaglinide (PrandiMet) for type 2 diabetes. Medical Letter on Drugs and Therapeutics 51(1313): 41-43

Metformin/glibenclamide-related interstitial lung disease: a case report. Sarcoidosis, Vasculitis, and Diffuse Lung Diseases 31(2): 170-173

Metformin/rosiglitazone combination pill (Avandamet) for the treatment of patients with Type 2 diabetes. Expert Opinion on PharmacoTherapy 8(9): 1353-1364

Metformin: Current knowledge. Journal of Research in Medical Sciences 19(7): 658-664

Metformin: From medieval age to new therapeutic targets. International Journal of Diabetes in Developing Countries 28(1): 31-31

Metformin: Midlife maturity, maiden charm. Indian Journal of Endocrinology and Metabolism 16(6): 1015-1018

Metformin: On Ongoing Journey across Diabetes, Cancer Therapy and Prevention. Metabolites 3(4): 1051-1075

Metformin: a diabetes drug for cancer, or a cancer drug for diabetics?. Journal of Clinical Oncology 30(21): 2698-2700

Metformin: a differential diagnosis for weight loss, altered bowel habits and B12 deficiency anemia in an elderly diabetic. Medical Journal of Malaysia 68(5): 441-442

Metformin: a metabolic disruptor and anti-diabetic drug to target human leukemia. Cancer Letters 346(2): 188-196